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Abstract 
 
The main aim of this work was to develop accurate and efficient methods for the 
verification of Intensity Modulated Radiotherapy (IMRT). IMRT is an advanced 
form of radiotherapy demanding extensive verification procedures to ensure 
treatments are delivered accurately. This requires comprehensive sampling of the 
complex dose distributions impacting on the tumour volume and radiation-
sensitive ‘organs at risk’.  
 
This work has focused on the use of electronic portal imaging devices (EPIDs) for 
verification purposes. Modern EPIDs are composed of a scintillator and an 
amorphous silicon detector panel with an array of photodiodes and thin film 
transistors. They are primarily used to verify the patient position during 
treatment by capturing transmission images, but they also have the potential to be 
used as efficient dose verification tools of high spatial resolution.  
 
Two complementary dose verification methods have been developed. One 
approach involves the calculation of portal dose using Monte Carlo (MC) methods. 
A MC model of the linear accelerator, in combination with the EPID, enables the 
dose to the detector to be predicted accurately and compared directly with 
acquired images. An alternative approach has also been developed. This utilises a 
clinical treatment planning system (TPS) to calculate the dose at the detector 
level, and convert this to predicted EPID intensity by application of a series of 
derived correction factors. 
 
Additionally, there have been numerous publications in the literature detailing 
problems in dosimetry caused by non-uniform backscatter to the imager from the 
model of detector support arm used in this work. Two novel methods to correct 
for this issue have been developed, a MC modelling solution and a matrix-based 
correction.  
 
These developed methods for IMRT dose verification have been applied both prior 
to and during treatment. When applied to pre-treatment verification, the MC 
solution is accurate to the 2%, 2 mm level (an average of 96% of points passing 
gamma criteria of 2%, 2 mm) and the TPS based method is accurate to the 3%, 3 
mm level (an average of 98% of points passing gamma criteria of 3%, 3 mm). Both 
verification methods achieve acceptable verification results during treatment at 
the 5%, 5 mm level (average gamma pass rates of 97% and 96% being achieved 
for the MC and TPS based solutions respectively). Furthermore, in initial clinical 
studies, both techniques have identified dose delivery errors due to changes in 
patient position or patient anatomy. 
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Chapter 1 
Introduction 
 
1.1 Cancer Incidence and Survival 
In the UK, more than one in three people will develop cancer in their life (Cancer 
Research UK 2011). Around 298,000 people were diagnosed with cancer in the UK 
in 2007; this equates to around 489 cases for every 100,000 people. Wales has the 
highest incidence of cancer in the UK, in 2007 there being 586 cancers per 
100,000 population; table 1.1 gives the rates of cancer in the UK in 2007 (Cancer 
Research UK 2011). Cancer is most common in older populations, over a third 
being diagnosed in those over 75 years of age, and so cancer rates are heavily 
influenced by the number of elderly people in the population. Therefore, quoted 
cancer rates are usually age standardised to take into account age differences in 
underlying populations, hence the European age standardised rate given in the 
table. 
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The incidence of prostate cancer is reported to be particularly high in Wales 
(Cancer Research UK 2011). However, some of this variation may be explained by 
differences in the availability and uptake of screening services for prostate-
specific antigen (PSA) across the UK (Cancer Research UK 2011, Brewster et al. 
2000). 
 
 England Wales Scotland N. Ireland UK 
Crude rate per 
100,000 
480.2 586.0 534.1 439.1 488.7 
European age 
standardised rate 
per 100,000 
371.4 415.8 403.0 388.2 377.0 
Table 1.1. Number of new cases and rates of cancer (all malignant tumours excluding 
non-melanoma skin cancer), 2007 (data from Cancer Research UK 2011). 
 
Continual improvements in cancer treatments enable a greater number of people 
to survive, cancer survival rates usually being quoted at 1, 3, 5 and 10 years post 
diagnosis. Survival is improving for the majority of cancer sites, the Welsh Cancer 
Intelligence and Surveillance Unit (2010) quoting 46% of males surviving five 
years from diagnosis in the period 2000-2004 compared to 31% in the period 
1985-1989, with female five year survival increasing from 45% in 1985-1989 to 
53% in 2000-2004.  They state that the majority of these increases can be 
attributed to prostate cancer for males for which five year survival has increased 
from 45% in 1985-1989 to 78% in 2000-2004, and for breast cancer in females for 
which five year survival has increased from 66% in 1985-1989 to 82% in 2000-
2004.  
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1.2 An Introduction to Radiotherapy  
Radiotherapy has been used in the treatment of cancer for over 100 years. It 
involves the use of ionising radiation in the form of X-rays, electrons, gamma rays, 
neutrons or protons. Electrons and protons are classed as ‘directly’ ionising 
radiation as they are charged particles that impart energy directly to matter, 
whilst X-rays, gamma rays and neutrons are classed as ‘indirectly’ ionising, energy 
being imparted in a multiple step process. X-ray or gamma photons firstly interact 
with the medium via interactions such as the photoelectric effect, Compton effect 
or pair production, these interactions releasing electrons that impart energy to 
matter, whereas neutrons predominantly interact with atomic nuclei releasing 
photons or electrons. Radiotherapy may be administered by external beams of 
radiation directed towards the tumour (external beam radiotherapy or 
teletherapy), by positioning radioactive material close to, or within, the tumour 
(brachytherapy), or by administering radioactive liquids with preferential uptake 
in a particular organ (radionuclide therapy). 
 
The main difficulty in treating cancers with radiotherapy is that since the tumour 
mass is usually situated either within or on the surface of a particular tissue or 
organ it is inevitable that healthy tissues will also receive a high dose of radiation. 
The aim of radiotherapy treatments is to deliver the highest possible dose to the 
tumour in order to maximise the probability of complete tumour regression whilst 
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restricting the dose to the normal tissue so that it is able to maintain its function 
after treatment.  
 
The key to successful radiotherapy treatment lies in the sensitivity of different 
tissues to radiation, tumours often being more sensitive to radiation than the 
nearby healthy tissues. Figure 1.1 gives typical tumour control probability (TCP) 
and normal tissue complication probability (NTCP) curves as a function of dose1. 
 
TCP curves are typically ‘sigmoid’ in shape, with minimal chance of cure at low 
doses, a rapid rise in cure-rate once a particular dose is received and an 
asymptotic approach to maximum effect. The NTCP curve follows a similar shape, 
radiotherapy being most successful in anatomical regions with the greatest lateral 
displacement between the TCP and NTCP curves. The ratio of tumour control 
probability to normal tissue complications probability for a particular dose is 
called the ‘therapeutic index’. In addition, radiotherapy treatments are usually 
‘fractionated’, i.e. the delivered dose is spread out over a number of treatments. 
Fractionated radiotherapy enables normal tissues to partly repair themselves 
between radiotherapy treatments (normal tissues preferentially repair over 
tumour cells), therefore maximising the therapeutic index. 
                                                            
1
 It should be noted that the term dose is used to mean absorbed dose throughout the 
thesis. 
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Figure 1.1. Typical tumour control probability (TCP) and normal tissue complication 
probability (NTCP) curves as a function of dose. 
 
 
1.3 An Introduction to IMRT 
Normal tissue complications limit the dose that can be delivered to the tumour. 
Intensity Modulated Radiotherapy (IMRT) is an advanced form of radiotherapy in 
which the intensity of each radiation beam is modulated, enabling greater 
conformity to the tumour volume. Increased sparing of organs at risk (OAR) in 
close proximity to the tumour reduces toxicity to these organs and also gives the 
potential for dose escalation, achieving greater tumour control. With increasing 
evidence that it provides improved treatment outcomes (McDonald et al. 2009, 
Staffurth 2010, Dirix and Nuyts 2010, Dirix et al. 2010, Jensen et al. 2010) IMRT 
has become the standard of care for many treatment sites.  
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Intensity modulation is achieved by breaking the beam down into many ‘beamlets’ 
of varying intensities shaped by a multi-leaf-collimator (MLC). The MLC is situated 
in the head of the linear accelerator and consists of typically 80 to 160 moveable 
tungsten ‘leaves’ (figure 3.10). IMRT is usually carried out using either ‘step and 
shoot’ or ‘sliding window’ (dynamic) techniques. The step and shoot method 
requires the beam to be turned off between MLC movements. The dynamic 
method involves moving the collimator leaves continuously with the radiation on.  
 
Conventional treatment planning uses a ‘forward’ method whereby the beam 
sizes, directions and weights are specified by the person preparing the plan, based 
on previous experience. The high number of parameters involved in complex 
IMRT dose distributions usually necessitates an automated approach. These dose 
distributions are achieved using ‘inverse’ planning techniques.  Inverse planning 
involves specifying the dose deposition objectives by identifying the dose that 
must be achieved in the tumour volume and the doses that must not be exceeded 
in any critical structures or normal tissues, giving each objective a level of 
importance. The IMRT optimisation process then determines the beam 
parameters (i.e. the number of beamlets and intensities required) that will give 
the best outcome. 
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There are two main categories of mathematical processes by which treatment 
planning software can carry out this optimisation process; stochastic and 
deterministic methods. Both methods seek the ideal dose distributions iteratively. 
The iteration processes run through a sequence of possible beam changes, each 
change being associated with a ‘cost function’, which is based on the degree by 
which the desired dose distribution is improved or worsened by the change. A 
simple example of a deterministic search algorithm is gradient descent. The 
problem with this method is that it is possible to get stuck in local minima and so 
the ideal dose distribution (global minimum) is not approached. Stochastic 
searches, such as simulated annealing, are characterised by some degree of 
random search behaviour, and so getting stuck in local minima can be prevented.  
 
Staffurth (2010) has presented a review of the clinical benefit for IMRT and 
identified 61 studies comparing IMRT with conventional radiotherapy. Toxicity 
related effects were reported to be consistently reduced for IMRT. In particular, it 
was reported that inverse-planned IMRT maintains parotid saliva production and 
reduces acute and late xerostomia during radiotherapy for locally advanced head 
and neck cancer, and reduces late rectal toxicity in prostate cancer patients 
allowing for safe dose escalation. Additionally it was reported that simpler 
forward-planned IMRT of the breast reduces acute toxicity and improves late 
clinician-assessed cosmesis compared with conventional tangential breast 
radiotherapy.   
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Recently, Intensity Modulated Arc Therapy (IMAT) has been introduced by linear 
accelerator and treatment planning system manufacturers, which allows similar 
or superior dose distributions to IMRT with reduced treatment time. In this 
technique, the radiation is delivered in arcs, rather than delivered from typically 5 
to 7 discrete directions. However, at the time of writing, our centre has only 
recently obtained a planning system able to support this treatment mode and no 
clinically satisfactory plans have as yet been produced. 
 
1.4 The Need for IMRT Verification 
An excessive dose of radiation leads to radiation necrosis of healthy tissues, whilst 
an inadequate dose would fail to kill the cancerous cells, in time leading to 
recurrence of the tumour. The importance of accurate and precise dosimetry and 
radiotherapy treatment planning therefore cannot be overemphasised. Advanced 
radiotherapy techniques, such as IMRT, require extensive verification 
measurements to ensure that the treatments are delivered correctly (Ibbott et al. 
2008, Ezzell et al. 2009). The Radiological Physics Centre in the United States 
reported in 2008 that 30% of the centres evaluated as part of an IMRT 
credentialing process failed to deliver IMRT to within 7% of the planned dose 
distribution (Ibbott et al. 2008). Differences between the planned dose and the 
dose delivered by the linear accelerator may arise from inaccuracies in the 
treatment planning system (TPS) dose calculation algorithm or from errors in 
IMRT treatment delivery. Furthermore, all dosimetry methods are associated with 
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uncertainties, and inter-fractional dose variations will occur due to patient 
positional errors and day-to-day anatomical variations (Castadot et al. 2010). 
 
Initial commissioning of IMRT requires thorough verification of the complex three 
dimensional dose distributions calculated by the treatment planning system. Due 
to the complexity of the treatments, most centres still verify these dose 
distributions on a patient by patient basis to ensure correct TPS dose calculation 
and treatment delivery by the linear accelerator prior to the patient being treated 
(Ezzell et al. 2009). Some centres additionally measure the dose delivered during 
treatment, a recommendation of the UK Report ‘Towards Safer Radiotherapy’ 
(Royal College of Radiologists 2008). 
 
Conventional dosimetric methods such as ionisation chamber, diode or 
thermoluminescent dosimeter (TLD), have limitations for IMRT verification in that 
they are only able to provide point by point sampling and so do not 
comprehensively sample what may be complex distributions with steep dose 
gradients impacting on both the tumour volume and OAR. Traditional film 
dosimetry, which provides very high resolution in 2D, is no longer an option for 
most centres, with film processors becoming obsolete as radiotherapy centres 
turn to digital picture archiving and communication systems (PACS). The main 
alternatives available are radiochromic film (that requires no chemical 
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processing), 2D arrays (composed of ion chambers or diodes) or electronic portal 
imaging devices (EPIDs).  
 
1.5 An Introduction to EPID Dosimetry 
EPIDs, which are primarily used for the verification of patient position during 
treatment by acquiring transmission images, are increasingly becoming the 
dosimeters of choice in this area (van Elmpt et al. 2008a, van Elmpt and Ezzell 
2009). Most centres already have EPIDs available on their linear accelerators 
(linacs), and so they provide cost effective absolute dosimetry with rapid read-out. 
In addition, the uncertainties created by non-uniform film response and 
differences in temperature or time between irradiation and analysis are 
eliminated. 2D arrays of ion chambers or diodes, even with the detector shift 
methods described for increasing their resolution (Spezi et al. 2006), are still 
unable to provide the sub-millimetre spatial resolution available from EPIDs or 
film. Spatial resolution is of particular importance for IMRT verification to ensure 
that the MLC leaves are being driven to the correct position during delivery.  
 
There are a number of EPID dosimetry approaches published in the literature, 
both pre-treatment to verify delivery before treatment commences and transit, or 
transmission, dosimetry to verify delivery during treatment of the patient. Table 
1.2 identifies some of the key papers published. Transmission methods either 
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evaluate the dose distribution at the plane of the detector or reconstruct the dose 
within the patient. Reconstruction can be achieved by back-projection methods 
(McNutt et al. 1996, Wendling et al. 2006, McDermott et al. 2006b) or by using 
fluence profiles extracted from the acquired images to calculate the dose within 
the patient (Partridge et al. 2002, Steciw et al. 2005, Renner et al. 2005, van Elmpt 
et al. 2007).   
 
‘A literature review of electronic portal imaging for radiotherapy dosimetry’ (van 
Elmpt et al. 2008a) points out the vast range of publications yet current lack of 
commercially available transit dosimetry solutions. ‘Dosimetry Check’ from Math 
Resolutions2, based on the methods presented by Renner et al. (2005), claims to 
be the first commercial EPID based transit dosimetry solution. Sankar et al. 
(2010), reported preliminary results using this software at the Institute of Physics 
and Engineering in Medicine (IPEM) Biennial Radiotherapy meeting, which are 
discussed in more detail in Chapter 7.  
  
                                                            
2
  http://www.mathresolutions.com/rtqasys.htm 
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Pre-treatment 
Verification 
(non-transit 
images) 
At detector 
plane 
2D 
Van Esch 2004, Siebers et al. 2004, Li et 
al. 2006, Nicolini et al. 2006, Parent et 
al. 2006, Parent et al. 2007, Greer et al. 
2009, Cufflin et al. 2010a 
Dose 
reconstructed 
within patient 
CT / phantom 
 
2D 
Warkentin et al. 2003  
3D 
Steciw et al. 2005, Renner et al. 2005, 
van Elmpt et al. 2007 
 
 
Transit 
(Transmission) 
Dosimetry 
 
At detector 
plane 
2D 
McNutt et al. 1996, McCurdy et al. 
2001, Spezi and Lewis 2002, Chin et al. 
2003, Chin et al. 2005, Chen et al. 2006, 
Nijsten et al. 2007a, Mohammadi et al. 
2006, Reich et al. 2006, Dahlgren et al. 
2002 
 
Dose 
reconstructed 
within patient 
CT 
 
1D 
Nijsten et al. 2007b, Piermattei et al. 
2007 
2D 
Wendling et al. 2006, McDermott et al. 
2006b 
3D 
McDermott et al. 2008, Partridge et al. 
2002 
Review Papers / Discussions 
van Elmpt et al. 2008a, van Elmpt et al. 
2009 
Table 1.2. Some key papers published on portal dosimetry techniques. 
 
 
1.6 Thesis Context and Objectives 
The work in this thesis was carried out at Velindre Cancer Centre (VCC) in Cardiff, 
Wales. VCC is one of the largest cancer centres in the UK, providing specialist 
cancer services to over 1.5 million people in South East Wales and beyond. 
 
The aims of this work were to develop accurate and efficient methods for the 
verification of IMRT, an advanced form of radiotherapy. The main focal point has 
been the development of EPID dosimetry for IMRT verification. Two methods have 
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been developed side-by-side, one method involving full forward Monte Carlo (MC) 
calculation of portal dose and the other utilising the treatment planning system to 
calculate the dose at the EPID level, and convert this to predicted EPID intensity. 
 
1.7 Thesis Outline 
This thesis is organised such that:  
 
Chapter 2 gives an introduction to the MC method and dose calculation 
algorithms, with Chapter 3 detailing the MC modelling and optimisation of 
parameters that has been carried out as a part of this work.  
 
Chapter 4 describes the MC modelling of the Varian aS500 EPID, paying particular 
attention to the modelling of the Varian imager support arm which is known to 
cause difficulties in portal dosimetry due to non-uniform backscatter (Siebers et 
al. 2004, Ko et al. 2004, Moore and Siebers 2005, Greer et al. 2009, Wang et al. 
2009).  
 
Chapter 5 demonstrates the use of the developed MC EPID model for pre-
treatment IMRT verification. 
 
Chapter 6 details INTREPID (INtegrated TReatment Planning and EPID 
Dosimetry), the method devised to calculate the dose at the EPID level within the 
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treatment planning system and convert to EPID intensity. The associated novel 
correction for non-uniform backscatter is also described. 
 
Chapter 7 extends the INTREPID method to the verification of delivery during 
treatment. 
 
Chapter 8, MC portal dosimetry, details the methods used for full-forward MC 
calculation of portal dose for transit dosimetry during treatment. The MC 
calculated dose to the patient is also calculated as a part of this process. 
 
Finally, Chapter 9 summarises the work in this thesis and identifies some areas for 
future work.   
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Chapter 2 
An Introduction to the Monte Carlo 
Method and Dose Calculation Algorithms 
 
 
2.1 An Introduction to Monte Carlo 
The MC method is known to be the most accurate dose calculation method in the 
presence of patient contour and tissue heterogeneities (Rogers 2006). The 
technique, so called because the possible particle interactions are sampled using 
random number generators, involves simulating the irradiation system. Accurate 
models of the radiation sources are required and the radiation transport 
determined using physical models for energy deposition and detailed specification 
of the properties of the different materials involved.  
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The term Monte Carlo was first used to describe random sampling of radiation 
transport at the end of the Second World War (Chetty et al. 2007). Increased 
computing power and the introduction of new MC codes have resulted in an 
enormous increase in MC studies in radiotherapy in recent years, with a doubling 
of papers on the subject every 5 years between the first Physics in Medicine and 
Biology paper in 1967 (which applied MC techniques to calculate the response of a 
NaI detector used to measure radiotherapy beam spectra (Bentley et al. 1967)) 
and 2000 when the numbers levelled off (Rogers 2006). To quote Chetty et al. 
(2007) “As a technique for calculating dose in a patient the underlying physical 
basis is much simpler in concept than analytic algorithms because the MC method 
consists of a straightforward simulation of reality and does not involve complex 
approximations nor models of dose deposition, but only a knowledge of the 
physics of the various interactions which have been well understood for over 50 
years in most cases”.  
 
This project uses the BEAMnrc package (Rogers et al. 2001), an upgraded version 
of the original BEAM code (Rogers et al. 1995). BEAMnrc is used for linac 
simulations and the associated code DOSXYZnrc, for calculations of dose 
distributions within a patient, phantom or EPID. BEAMnrc allows easy modelling 
of radiotherapy linear accelerators, and has been bench-marked and used 
extensively in the scientific literature and is therefore often considered to be the 
gold standard for MC simulations for radiotherapy applications (Hasenbalg et al. 
2008). The BEAMnrc package is based on the EGS (Electron Gamma Shower) MC 
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code (Nelson et al. 1985, Kawrakow 2000) which was developed at the Stanford 
Linear Accelerator Center (SLAC) and the National Research Council of Canada 
(NRC). Linac models are built by specifying which “component modules” are to be 
used and in what order. It is possible to represent each individual part of the linac 
using these component modules.  
 
Up until 2005, all BEAMnrc simulations generated “phase-space” files recording 
the type, energy and direction of each particle crossing a specific plane. These 
phase-space files are used to feed subsequent MC simulations, either DOSXYZnrc 
simulations in a phantom or patient, or further BEAMnrc simulations. For example 
a phase-space file above the linac jaws may be created to increase the speed of 
simulations, avoiding repetition of simulating particles through static geometries. 
In releases of BEAMnrc since 2005 an additional option to use a full BEAMnrc 
simulation of a treatment head as a particle source for DOSXYZnrc simulations has 
been available, with the obvious advantage that intermediate phase space data 
need not be stored, therefore preventing data storage issues. For calculations with 
the precision required in a clinical setting this can save tens of GBytes of disk 
storage. However, the extra time required to perform a full linac simulation to 
generate source particles results in reduced efficiency. Kawrakow and Walters 
(2006) directly compared efficiency between phase space sources and full 
BEAMnrc simulation sources. They reported that with efficient use of variance 
reduction techniques, such as photon splitting within DOSXYZnrc and directional 
bremsstrahlung splitting within BEAMnrc (see page 20), BEAMnrc simulation 
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sources are only 3 – 13% less efficient than simulations with phase-space file 
sources, eliminating the need for storage of intermediate phase space. Figure 2.1 
illustrates a Monte Carlo model of a linear accelerator. 
 
                        
 
Figure 2.1. A Monte Carlo linear accelerator model A) X-Z cross-section B) Y-Z cross-
section and C) Diagram showing photon tracks. 
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MC transport relies on the availability of cross-section datasets for each physical 
process simulated.  BEAM material cross section data are created with the pre-
processor PEGS4 (Nelson 1985) and are based on material compositions and 
densities set out in the International Commission on Radiation Units (ICRU) 
Report 37 (ICRU 1984). There are 2 data sets readily available, ICRU 521 and ICRU 
700, which correspond to kinetic energy thresholds for secondary electron 
production of 10 and 189 keV respectively.  
 
MC transport of electrons is significantly more complicated than for photons, 
electrons undergoing a very large number of collisions during the slowing down 
process. Condensed history techniques are used to condense a large number of 
these electron collisions into a single step, the shorter the step the more accurate 
the simulation. Condensed history techniques were first described by Berger in 
1963, this technique now forming the basis of all electron-photon MC codes. With 
the aim of improving electron transport at low energies EGS introduced 
parameters ‘ESTEPE’ and ‘SMAX’ which represent the maximum fractional energy 
loss per electron step and the maximum step length allowed. This can, however, 
result in artefacts when crossing boundaries where multiple step assumptions are 
not valid anymore. To overcome this boundary crossing problem BEAM originally 
incorporated ‘PRESTA’ (at proximity to interface or boundary, the electron step is 
shortened) (Bielajew and Rogers 1987). PRESTA was the default boundary 
crossing algorithm (BCA) up until 2006, after which the ‘EXACT’ algorithm became 
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the default. The EXACT BCA was introduced in EGSnrc to eliminate a known 
fluence singularity caused by forcing a multiple scattering event at a boundary 
(Walters and Kawrakow 2007). In the EXACT case, electrons are transported in 
single elastic scattering mode as soon as they are within a specified distance from 
the boundary.  
 
Transport cut offs and range rejection techniques are used to increase calculation 
speeds, and when used correctly should improve efficiency without a significant 
change in the result. If the particle energy falls below the relevant transport cut off 
(ECUT for electrons and PCUT for photons), the particle trajectory is terminated 
and its energy deposited in the current region. Electron range rejection involves 
terminating electron tracks with a residual range that does not allow them to 
reach the scoring plane of interest. For linac simulations 2 – 3 MeV is chosen 
(Sheikh-Bagheri and Rogers 2002).  
 
Variance reduction techniques are used in MC simulations to decrease the 
calculation time to reach a certain statistical variance in the simulation outputs. 
Bremsstrahlung splitting creates a higher number of photons with reduced 
statistical weights. Directional Bremsstrahlung Splitting (DBS) was introduced by 
Kawrakow et al. (2004) and results in greater efficiency than bremsstrahlung 
splitting methods used previously. If a primary charged particle undergoes a 
CHAPTER 2. AN INTRODUCTION TO THE MONTE CARLO METHOD AND DOSE 
CALCULATION ALGORITHMS 
     
 
21 
 
bremsstrahlung or annihilation event then the event is split ‘NBRSPL’ times, the 
energy deposition ‘weight’ of the resultant photons being multiplied by NBRSPL-1. 
Photons aimed at the splitting field are kept and are considered ‘non-fat’ (low 
weight), with random number Russian Roulette being played on those photons 
aimed away from the splitting field. The photon survives if the random number is 
less than a survival threshold of NBRSPL-1, surviving photons having their weight 
multiplied by NBRSPL (these are now considered ‘fat’). This technique reduces 
calculation times as fewer particles aimed away from the splitting field are 
tracked. DBS is very efficient for photon fluence calculations but results in only a 
few ‘fat’ charged particles reaching the plane of interest. Charged particle splitting 
must therefore be carried out to “recover” the charged particles.  
 
Efficiency improvements within the DOSXYZnrc simulation may be achieved by 
making use of the particle recycling or photon splitting options. Kawrakow and 
Walters (2006) found that use of photon splitting increases the dose calculation 
efficiency by a factor of up to 6.5, depending on beam energy, field size, voxel size, 
and the type of secondary collimation used in the simulation. They found the 
optimum efficiency with photon splitting to be 55% higher than that with particle 
recycling. In photon splitting, all photons are split into n_split photons, each with a 
weight equal to n_split-1 times the weight of the original photon. At each 
interaction site charged particles and/or scattered photons are produced, Russian 
Roulette being played on all scattered photons with a survival probability of 
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n_split-1. Surviving photons have their weight increased by n_split so that their 
weight is equal to that of the original photon before splitting. All charged particles 
survive with weight equal to n_split-1 times the original weight.  
 
Whilst the dose calculation technique which shows closest agreement between 
calculation and measurement is obviously the more desirable, full MC techniques 
are computationally intensive and still very time consuming, and so are not 
suitable for patient dose calculations that require near real-time interaction. 
Faster MC techniques, most based on the code ‘VMC’ (Kawrakow et al., 1996), have 
been implemented in some of the most up-to-date treatment planning systems. 
These techniques were first applied to electron beam simulation, but modified 
versions are now used for the simulation of photon beams (Gardner et al. 2007, 
Hasenbalg et al. 2008, Kunzler et al. 2009). These codes are faster due to the 
intensive use of variance reduction techniques and a much faster implementation 
of the condensed history technique for charged particle transport, and are often 
limited to simulating the beam collimation system and patient dose. With multiple 
core PCs now readily available, faster MC techniques are likely to form the dose 
computational basis of treatment planning systems in the future, although this is 
not the case generally at present.  
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2.1.1 Statistical Uncertainties and Run-Times in MC Simulations 
MC simulations are subject to statistical uncertainties. In the current application 
these are due to uncertainties in the accelerator head (i.e. source) simulation and 
the random nature of dose deposition. If a pre-calculated phase-space is used, re-
using phase space particles in the phantom simulation will improve statistical 
uncertainties in the result, to the level of statistical uncertainty in the phase-space 
file.  
 
Beamnrc / DOSXYZnrc use the history-by-history method for calculating 
uncertainties. The estimate of the uncertainty (standard error of the mean,
x
s ) of a 
scored quantity X is given by 
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where N is the number of histories and Xi is the contribution to the scored 
quantity by independent history i. When calculating uncertainties it is important 
to correlate a primary particle with its ‘secondaries’ as treating the secondary 
particles as independent histories results in an underestimate of the uncertainty. 
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Statistical uncertainties are dependent upon the number of histories per voxel. 
Therefore, for a certain number of histories, decreasing the voxel size in the 
simulation increases the statistical uncertainty. For IMRT simulations involving 
large intensity gradients, a high resolution (and thus small voxel size) of the order 
of 1 – 2 mm is required. Commissioning of the MC MLC requires even finer voxels 
to accurately verify the rounded leaf-ends and inter-leaf leakage.  
 
For standard BEAMnrc patient simulations with the region of interest at or close 
to the linac isocentre, the number of particles, or histories, required to give a 
certain statistical accuracy is given by equation 2.2 (BEAM 1997). 
 


	


     (2.2) 
where N is the number of histories to run, s is the desired fractional uncertainty, 
µen is the effective energy absorption coefficient for the medium, A is the area of 
the beam aperture projection at isocentre and Vvoxel is the volume of the 
simulation voxels. It is normally assumed that the body composition of the patient 
is effectively water equivalent and so a value of 0.03 cm-1 is usually used for µen. 
The greater the number of histories the longer the simulation time, but the lower 
the final statistical uncertainty in the resulting dose distribution. The smaller the 
voxel size the greater the number of histories required to reach a particular 
statistical uncertainty.  
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2.1.2 Distributed Computing 
The main downside of MC simulations is the lengthy calculation time required. 
Pencil beam (PB) and Collapsed Cone (CC) dose calculations (section 2.2) take 
only a matter of minutes to run on a single PC, whereas the clinical MC simulations 
presented in this thesis would take many weeks of run-time on a single PC. 
Although the variance reduction techniques described above help to make the 
simulations faster, to enable run-times for the simulations described in this thesis 
to become clinically acceptable they must be distributed amongst a larger number 
of processors simultaneously. The parallel nature of MC simulations makes it 
relatively straightforward to distribute simulations across multiple machines. 
Different particle histories are run simultaneously on different computers and, as 
each radiation history is inherently independent, the final results are neither 
biased by the physics nor the statistics. 
 
There are a number of methods for distributing simulations across a number of 
processors. The easiest method to implement is a cluster of machines with 
homogeneous software and hardware that share a common file system, e.g. a 
‘Beowulf’ cluster (Love et al. 2000). These are dedicated machines to the process 
in question and as ownership is typically local, workload is usually predictable 
and simpler to co-ordinate. High throughput computing (HTC) systems, on the 
other hand distribute simulations across processors that do not necessarily share 
a common file system or memory. These processors are not dedicated to HTC but, 
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since they are not constantly in use, their ‘idle time’ (evenings and weekends for 
example) may be used for intensive computations.  
 
The release of the multi-platform version of BEAMnrc in 2005 enabled the 
BEAMnrc code to run on Windows NT/2000/XP and on Apple Mac OSX, 
immediately making more resources available for HTC. The idea behind ‘Grid’ HTC 
systems, such as the National Grid Service (NGS)3, is to provide computing power 
for all that require it by simply ‘plugging in’. A platform or web portal can be 
provided to enable simulations to be submitted, and so the use of resources is not 
restricted to computer experts in the field. Installation of BEAMnrc and 
DOSXYZnrc on every computer on a ‘Grid’ system is not feasible due to limited 
disk space. Therefore, a data shipment necessary for running the simulations must 
be transferred to the executing processor as and when one becomes available. 
 
When this project was started simulations were run on a cluster of 4 machines 
running SGI IRIX 6.5, each with 8 500MHz MIPS R14000 processors and 8GB of 
shared memory. Job submission was through Condor4 (Litzkow et al. 1988), a 
specialized workload management system, or ‘resource broker’ for 
computationally intensive jobs. Condor provides resource monitoring, resource 
management and a job queuing mechanism. Users submit their parallel computing 
jobs to Condor, which places them in a queue and chooses which resources to use 
                                                            
3
 http://www.ngs.ac.uk/access.html 
4
 http://www.cs.wisc.edu/condor/ 
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for the job. Condor is highly configurable, for example, it can be set up only to start 
a job when the keyboard has not been used for a specified period of time and to 
stop the job once a keystroke has been detected. 
 
When using this cluster, the multiple BEAMnrc and DOSXYZnrc input files 
required for a simulation had to be created manually, as did the combining of 
output files following the simulation. Matlab5 scripts were therefore written to 
‘split’ input files. Output files were combined using the DOSXYZnrc ‘IRESTART = 4’ 
option, which combines the multiple outputs into a single 3D dose file. This option 
enables calculation of the overall uncertainty within DOSXYZnrc. Run-times took 
approximately 2.5 hours per IMRT segment for the BEAMnrc part of the run 
(when all processors were available) and an average of 1.5 hours per segment for 
DOSXYZnrc, times being dependent on segment size.  
 
All MC simulations are now run on our recently developed RTGrid service6 
(Downes et al. 2009). The RTGrid system was designed to enable MC simulations 
of treatment plans using a variety of MC codes utilising resources as and when 
they become available. Access to the underlying HTC system is through a web 
interface, or ‘portal’ that facilitates job parameterisation and management. The 
running of the simulation is controlled by the ‘experiment manager’ that interacts 
                                                            
5
 http://www.mathworks.com 
6
 https://rapanui.cs.condor.cf.ac.uk/gridsphere/gridsphere?cid=experimentstab 
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with the RTGrid database and monitors changes to the simulation status, such as 
whether the simulation is ‘pending’, ‘running’ or ‘completed’ (figure 2.2). The 
RTGrid system currently supports four resource brokers: (1) Condor, (2) Globus 
(Foster 2005), (3) GridWay (Huedo et al. 2005) and (4) a broker connecting to the 
NGS, referred to as the RTGrid broker.   
 
Figure 2.2. An image of the RTGrid Portal showing percentage of simulations at each 
stage. 
 
For the work in this thesis, jobs submitted via the RTGrid portal were submitted to 
the Cardiff University Condor pool of Windows XP SP2 PCs, of which between 200 
and 1200 are available at any given time. The processors on the machines are 
mainly Pentium-4s, and memory varies amongst machines from 512 to 2048 MB. 
200 of the machines are dedicated, whereas the remainder belong to departments 
within the university network and so are only available when not being used for 
other purposes.  
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For the experiment manager to successfully run an experiment the files have to be 
laid out in a particular way, but all other aspects, such as the splitting of input files 
into the required number for the simulations, the combination of the output files 
following completion of the simulation and the calculation of the overall 
uncertainty, are handled automatically. 
 
 The transition to running simulations on the RTGrid service, combined with a 
shift from running the IMRT segments in static mode to ‘Step and Shoot’ mode 
(see section 3.2) and the use of photon splitting as opposed to photon recycling in 
simulations, has resulted in a speed up of up to a factor of 10 for IMRT plans from 
the initial simulations run on the SGI cluster. The full forward exit dosimetry 
simulations described in Chapter 8 are particularly computer intensive due to the 
fact that the phantoms are required to be very large and of high resolution, and 
IMRT simulations for portal dosimetry have to be run beam by beam (IMRT plans 
consist of up to 14 beams). The RTGrid enables even these results to be obtained 
overnight, making this process feasible for clinical purposes. 
 
2.2 An Introduction to Dose Calculation Algorithms 
All IMRT plans carried out at VCC are currently planned and optimised on 
Oncentra MasterPlan (OMP, Nucletron, The Netherlands).  OMP currently offers 
two dose calculation algorithms for photon beams, the pencil beam (PB) 
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algorithm, and the collapsed cone (CC) algorithm (Ahnesjö and Aspradakis 1999). 
In addition, there are presently 2 version releases of each of these algorithms, the 
‘Classic’ implementation, and the newer ‘Enhanced’ implementation.  
 
PB and CC algorithms provide somewhat different methods and accuracies for 
calculation of the dose deposited within the medium by interactions with the 
incident radiation (see Section 2.2.2). In general terms the dose delivered to the 
patient or phantom is calculated by convolution of the energy released with pre-
calculated energy deposition kernels, describing the dose distribution delivered 
by a primary photon in the volume surrounding its interaction point. Accurate 
calculation of the energy released requires knowledge of the energy fluence of the 
treatment beam.  
 
2.2.1 Energy Fluence from a Clinical Beam 
An energy fluence distribution denoted by ψtot(x,y) is defined as the amount of 
radiant energy incident on area ΔA at position (x,y) traversing a plane 
perpendicular to the beam (equation 2.3), i.e. 
∑ ∆
⋅
=
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iEi
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where EiN (x,y) is the number of photons with energy iE incident at (x,y) (Oncentra 
MasterPlan v3.3 Physics and Algorithms). 
 
In clinical beams, the total energy fluence is comprised of both primary photons, 
and scattered photons from irradiated parts of the treatment head. The total 
energy fluence can therefore be represented as:  
),:,(),(),( yxAyxyx indirectdirecttot Ψ+⋅Ψ=Ψ η   (2.4) 
where ),( yxdirectΨ  is the open beam energy fluence of non-scattered photons 
directly from the source,  ),( yxη  describes a possible modulation of the open 
beam of direct particles, A is a formal variable to represent the state of all the 
aperture setting parameters (for example, MLC settings), and ),:,( yxAindirectΨ  is 
the energy fluence of indirect photons scattered at least once in the treatment 
head (“head scatter”). Furthermore, the scatter part of the energy fluence can be 
divided into contributions from the flattening filter, the collimators and any 
auxiliary modulators, such as wedges, filters, blocks and trays (equation 2.5). 
modulatorsscollimatorfilter  flattening Ψ+Ψ+Ψ=Ψindirect      (2.5) 
In OMP the direct and head scattered energy fluences are calculated once and 
stored in separate 2D matrices for each beam, to be employed in patient dose 
calculations.  The matrices are determined at a reference plane distance, usually 
the isocentre (100 cm from the effective radiation source). Beam divergence is 
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considered by inverse square law scaling, using the target as the source origin 
focus for the direct fluence, and using the flattening filter as the effective focus for 
the indirect fluence (the flattening filter being the greatest source of scattered 
radiation).  
 
The ‘enhanced’ versions of the photon dose calculations include more detailed 
modelling of the direct energy fluence. The resolution of the energy fluence grid is 
1 mm in the enhanced implementation, but 2.5 mm in the ‘classic’ implementation.  
The enhanced version also includes much more detailed modelling of MLC 
rounded leaf-ends and inter-leaf leakage using ray-tracing methods. In the classic 
dose calculation algorithms the transmission through jaws and MLC leaves is 
included in the indirect (head-scatter) fluence, but in the enhanced algorithms this 
transmission is included in the direct fluence. A further advantage of the enhanced 
algorithms is the speed-up for IMRT dose calculations. The classic versions sum 
the individually calculated doses from each segment, whereas the enhanced 
versions sum the fluences for all segments in a beam, before performing a single 
dose calculation. 
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2.2.2 Dose Calculation using Convolution Kernel Models 
The energy deposition by secondary particles around a primary photon 
interaction site is referred to as a point kernel. Convolution kernel models use the 
fact that in homogeneous media the point kernel is independent of location, 
making point kernels suitable for pre-calculation using MC methods. Convolution 
of these point kernels with the calculated TERMA (total energy released in the 
medium) for the clinical beam enables the dose within the medium to be 
calculated. The dose D to point r is given by: 
                                              
∫
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−= ∫     (2.7) 
where T(r’) is the TERMA at r’, h(r – r’) is the point spread kernel about point r’, µ 
is the linear attenuation coefficient, ρ is the density and ψ(r’) is the primary 
photon energy fluence  at r’. 
ρ
µ
is known as the mass absorption coefficient of the 
medium. 
 
KERMA (kinetic energy released in the medium) is a familiar term to those in the 
radiotherapy field and TERMA is analogous to the collision part of KERMA, kcol, 
(equation 2.8) as energy lost to radiative interactions are not included. The term 
TERMA was introduced by Ahnesjo et al. in 1987. 
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colk = ψρ
µen     (2.8) 
where 
ρ
µ en is the mass energy absorption coefficient. 
 
Full convolution dose calculations are very time consuming and unsuitable for 
dose calculation within a clinical setting. If the density matrix used for the patient 
dose calculation is composed of N3 voxels, the number of calculations required to 
compute the dose contribution at each location from all the surrounding points 
would be N6 (Mackie et al. 1998). For this reason further approximations are 
required. The CC algorithm is an approximation to a point kernel model designed 
to speed up dose calculations whereas the PB algorithm is based on pencil kernels.  
 
Figure 2.3.  Energy deposition kernels. A) a point kernel B) a pencil kernel C) a planar 
kernel. 
 
Figure 2.3 illustrates the different kernels used in clinical dose calculations. A 
point kernel describes the energy deposition in an infinite medium around a 
primary photon interaction site, a pencil kernel describes the energy deposition in 
a semi-infinite medium from a mono-directional pencil beam and a planar kernel 
is the energy deposition from a broad parallel beam.  
A) B) C) 
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Clinical situations are far more complex than those involving monoenergetic 
beams incident on homogeneous slabs. Polyenergetic kernels representing the 
clinical beam can be calculated as a sum of monoenergetic kernels with 
appropriate weights according to the spectrum of primary photons (Ahnesjo 
1989), and point kernels can be scaled according to the density distribution 
(Mackie et al. 1985, Mohan et al. 1986, Ahnesjo et al. 1987). Off-axis beam 
softening and beam hardening at depth also need to be considered. 
 
The CC algorithm is a full 3D superposition / convolution dose calculation 
algorithm based on point kernels.  The algorithm gets its name from the fact that 
each point kernel is divided in 3-D into a number of variably spaced angular bins 
(or ‘cones’) and it is assumed that the energy released within each cone is 
transported only along its axis. As the energy released from a primary photon 
interaction is mainly concentrated in the forward direction, the density of cones in 
this direction is greatest.  OMP typically uses 106 cones, 60 in the forward 
direction, 40 laterally and 6 in the backward direction from the kernel origin 
(figure 2.4), although this can be adjusted by the vendor upon request with a 
greater number improving accuracy at the expense of additional computation 
time. 
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Figure 2.4. Angular binning of the point kernel in the CC algorithm for a beam vertically 
down. The algorithm gets its name from the fact that each point kernel is divided in 3-D 
into a number of variably spaced angular bins (or ‘cones’) and it is assumed that the 
energy released within each cone is transported only along its axis.  (Image reproduced 
from Oncentra MasterPlan v3.3 Physics and Algorithms.)  
 
A ray trace is performed to all calculation voxels (of 1 mm resolution for the 
enhanced algorithm, and of 2.5 mm resolution for the classic version), and the 
amount of radiant energy released in each voxel is determined. The TERMA is 
separated into 2 parts, the part due to energy released due to primary photons, 
and the scatter part, which is transported separately. The effects of beam 
hardening and off-axis beam softening are included in the ray trace.  
 
Figure 2.5.  The parallel lines along which the energy released is transported in the CC 
algorithm. The dots at the centre of each voxel represent the TERMA calculation points. 
(Image reproduced from Oncentra MasterPlan v3.3 Physics and Algorithms.) 
 
Beam direction 
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The discretised point kernels are then used to transport the energy released, until 
the energy is deposited as absorbed dose. The transport is performed along sets of 
parallel lines, or pipes, each set corresponding to a specific direction of the 
discretised point kernel (figure 2.5). The number of pipes in each set is 
determined by the requirement that each voxel should be passed by at least one 
pipe in the set. For each voxel encountered along a pipe the energy absorbed in 
the voxel is calculated and the energy released in the voxel in the direction of the 
transport line is added. For each direction the kernels are parameterised by  
2)(
r
Ae
rh
ar−
=         (2.9) 
where r indicates the distance to the interaction point, a describes the range of 
energy transport from the interaction site, and A represents the fraction of energy 
transported in the given direction per unit solid angle. Two sets of point kernels 
are used in OMP, one to redistribute the energy released due to primary photons 
(to give the primary dose), and one to redistribute the energy released due to 
scattered photons (to give the phantom scatter dose). Both sets of kernels are 
scaled for the presence of heterogeneities. Due to the beam divergence, a kernel 
tilt correction is also applied.  
 
The calculation time is proportional to the number of directions used for kernel 
discretisation (M) and the number of voxels (N3). Increasing both the number of 
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directions and the number of voxels would increase accuracy, at the expense of 
calculation time (equation 2.10). 
 
Calculation time  α  N3M     (2.10) 
 
Pencil kernels form the basis of the PB algorithm and result in a considerable 
speed up of calculation time. The PB algorithm within OMP calculates dose within 
the patient using a one dimensional convolution along fan–lines. Depth dose 
curves are used to obtain an effective energy spectrum for clinical beams, which in 
turn is used to obtain poly-energetic pencil kernels, derived by superposing mono-
energetic kernels. At each depth z, the poly-energetic energy deposition kernel in 
OMP is parameterised as  
r
eBeA
zr
p rbz
ra
z
zz −− +
=),(ρ    (2.11) 
where Az, az, Bz and bz are depth dependent parameters determined by least 
square fitting. az is larger than bz and so the two terms are interpreted as the dose 
components due to primary dose and scatter dose. Separating the kernel into 
primary and phantom scatter dose fractions in this way improves the 
heterogeneity correction, an equivalent path length correction being used for the 
primary dose contribution (Ahnesjö and Trepp 1991, Ahnesjö et al. 1992, 2005).  
 
The PB algorithm is known as a ‘type a’ algorithm, and CC as a ‘type b’ algorithm 
(Knöös et al. 2006). Type a algorithms are primarily based on equivalent path 
CHAPTER 2. AN INTRODUCTION TO THE MONTE CARLO METHOD AND DOSE 
CALCULATION ALGORITHMS 
     
 
39 
 
length scaling for inhomogeneity corrections and do not account for the effects of 
lateral and backscattered radiation, whereas type b algorithms model lateral 
scatter (in an approximate way). Type a algorithms therefore have known 
limitations in heterogeneous media, particularly in close proximity to tissue 
boundaries. In regions with few inhomogeneities, such as the prostate, studies 
have shown there to be only minor differences between dose distributions 
calculated by type a and type b algorithms (Aspradakis et al. 2003, Knöös 2006). 
The more heterogeneous the region the greater the advantage of moving to a more 
sophisticated calculation algorithm. It should also be noted that the CC method in 
OMP calculates dose to the actual medium, as does MC, rather than dose to water. 
Average CC doses are therefore 1-2% lower than PB doses for all treatment sites 
as the dose to soft tissue is about 1–2% lower than in water due to slight 
differences in atomic composition and hence mass energy absorption coefficients.  
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Chapter 3 
Monte Carlo Modelling of the Linear 
Accelerator and Multi-Leaf Collimator 
 
3.1 Monte Carlo Modelling of the Linear Accelerator 
3.1.1 Introduction 
This chapter will describe the MC modelling of the Varian 2100CD linacs at VCC. 
VCC currently has three 2100CDs, capable of treating both 6 MV and 10 MV 
photon ‘energies’7. These three linacs are matched (i.e. tweaked to produce the 
same energy and beam data) to enable transfer of patients between machines to 
maximise efficiency and ensure continuity of patient treatments in the event of a 
machine requiring repair. Conventionally 6 MV is used to treat the thinner regions 
                                                            
7
 By convention, the voltage is used to characterize X-ray beams, there being a 
spectrum of energies up to the maxima of 6 MeV and 10 MeV. 
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of the body, such as the head and neck region, and 10 MV to treat the thicker areas 
such as the pelvis region due the increased penetration at higher energy. The aim 
of this work was to model these linacs accurately to enable simulation of clinical 
IMRT plans. 
 
3.1.2 Methods 
This project began with the modelling of the Varian 2100CD linac in 10 MV mode 
using the BEAMnrc software, the linac in 6MV mode previously being modelled 
and validated as part of an earlier project (Spezi and Lewis 2002, Spezi 2003, Chin 
et al. 2003, Chin et al. 2005). This required the confidential linac specification data, 
detailing the materials and dimensions of all linac components provided by the 
vendor, Varian Medical Systems. Component modules SLABS, CONS3R, FLATFILT, 
CHAMBER, SLABS and JAWS were used to model the accelerator target, primary 
collimator, flattening filter, ion chamber, mirror and secondary collimators 
respectively. The MLC, one of the most challenging geometric structures to model 
in a linac head, was not included in the initial modelling and so is described in the 
next section. A parallel beam of monoenergetic electrons of energy 10 MeV and 
beam width 0.1 cm was initially used as these are the nominal values provided by 
the manufacturer.  
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Cross section dataset ICRU 521 was selected, corresponding to thresholds of 
secondary electron production of 0.01 MeV, based on material compositions and 
densities set out in ICRU Report 37 (1984). ECUT (the electron transport cut off) 
and PCUT (the photon transport cut off) were set to 0.7 MeV and 0.01 MeV 
respectively for linac simulations. DBS (see Chapter 2) was used to increase 
calculation efficiency, with a splitting number of 1000. Although the optimal 
setting for DBS would vary with the details of the accelerator being simulated, 
Kawrakow et al. (2004) suggest that setting a value of 1000 results in near 
optimum performance for all set-ups, adjustments around this value possibly 
increasing efficiency at most by 15%.  
 
In 2003 Verhaegen and Seuntjens presented a topical review of MC modelling of 
external photon beams. They suggested firstly fine tuning the primary electron 
energy by plotting the depth dose of a (10 × 10) cm2 field and comparing it with 
measured data. All measured data presented here were measured previously in a 
water tank, depth doses with a Scanditronix RK cylindrical ionization chamber 
with an active volume of 0.12 cm3 and profiles with a Scanditronix photon diode. 
Once an energy match has been found, Verhaegen and Seuntjens then suggest fine 
tuning the width of the electron beam by plotting profiles of large field sizes in air 
or at shallow depths in a phantom. The spot size of the primary electron beam is a 
crucial parameter to which calculated dose and fluence distributions are sensitive. 
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Depth doses should be constantly checked to ensure that a change in the source 
size has not affected the energy of the emerging beam.  
 
Depth doses ((10 × 10) cm2 fields) and profiles ((35 × 35) cm2 fields) were plotted 
in homogeneous water phantoms created using DOSXYZnrc. The primary electron 
energy was varied between 9.5 and 10.5 MeV and the source size varied between 
0.5 and 2.5 cm until the best match was obtained. A wider range of profiles were 
then plotted in order to verify the match. Depth doses were normalised at 10 cm 
deep and profiles at 9 cm deep, the percentage depth dose being applied in order 
to retain the dose relative to the maximum dose on the central axis (dmax). All 
comparisons between Monte Carlo and measured data were carried out using 
Matlab software. 
 
At the time this work was initiated it was thought that IMRT prostate treatments, 
like conventional prostate treatments, would be planned and delivered at 10 MV 
due to the increased penetration over 6 MV, hence the modelling of the linac in 10 
MV mode. However, more recent experience has shown that IMRT dose 
distributions of equal quality can be obtained at 6 MV. 6 MV IMRT treatments are 
often recommended for a number of reasons such as minimising neutron 
production and improved TPS calculation for small beamlets (Welsh et al. 2007). 
Therefore a clinical decision was made at our centre that all IMRT treatments 
would be carried out at 6MV. As a result, most work in this thesis has been carried 
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out using a model of a 6 MV linac, developed as a part of previous projects (Spezi 
and Lewis 2002, Spezi 2003, Chin et al. 2003, Chin 2005). The 10 MV model has 
however been validated and is available should the clinical need arise. For 
completeness, the results of measurement versus the MC 6 MV model have also 
been included here. The 6 MV and 10 MV linac models are very similar, the only 
differences being the energy, source size, target and flattening filter design and 
composition.  
 
In the latter stages of this project, photon splitting was introduced within 
DOSXYZnrc simulations using ‘ISOURCE9’ (a full linac simulation source, as 
described on page 17). As stated in Chapter 2, Kawrakow and Walters (2006) 
found that use of photon splitting increases the dose calculation efficiency by a 
factor of up to 6.5, although the optimum value varies with machine and 
simulation parameters, efficiency being given by equation 3.1. Therefore the 
optimum value of photon splitting for our set-up was determined. 
Ts
e 2
1
=   (3.1) 
where e is the efficiency, s the uncertainty and T the CPU (Central Processing Unit) 
time. 
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Additionally, a jaw position dependent correction for backscatter from the linear 
accelerator collimating jaws to the monitor chamber has to be performed for 
Varian linacs. The method used was that devised by Liu et al. (2000), who used MC 
simulations to calculate the ratio of backscattered radiation to forward radiation 
at the monitor chamber. The amount of backscattered radiation for any field 
setting was then computed as a compound contribution from both the X and Y 
jaws, which was used to calculate the change in photon output. Liu et al. found a 
2% increase in photon output when increasing the field size from (10 × 10) cm2 to 
(40 × 40) cm2. 
 
3.1.3 Results 
 
 
Figure 3.1. Monte Carlo depth dose for 10.2 MeV primary electron beam compared with 
measured data, normalised at 10 cm deep. Vertical error bars are shown indicating ±1 SD 
on MC data. 
 
 
The best match between MC simulation and measurement was found for a 
primary electron energy of 10.2 MeV and source width of 0.11 cm. These values 
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compare relatively well with those determined by Sheikh-Bagheri and Rogers 
(2002) i.e. a beam energy of 10.5 MeV and source size of 0.15 cm. The MC and 
measured percentage depth dose curves are given in figure 3.1, differences 
between measured and MC data being generally within 0.5%.   
 
 
The effect of modifying the source width (for a circular source) on the 10 MV beam 
profile is shown in figure 3.2 below, the black profiles representing measured 
data, the red, green and blue plots representing the MC data for source sizes of 
0.10, 0.18 and 0.24 cm respectively. The profiles correspond to depths of 2.5, 9, 
and 15 cm. This diagram demonstrates the importance of plotting profiles at 
shallow depths or in air when estimating the source size, shallow profiles being 
much more sensitive to any changes. The final MC profiles, for a 0.11 cm source 
size, versus measurement are given in figures 3.3 and 3.4.  
 
Figure 3.2. Effect of changing the width of the primary electron beam on profile shape. 
The effect is more visible at shallow depths. The curves were normalised at 9 cm deep and 
the percentage depth dose applied in order to retain the dose relative to dmax.  
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Figure 3.3. Y direction Profiles demonstrating the agreement between MC and 
measurement for the 10 MV MC model, 0.5 cm voxels A) 35 cm × 35 cm and B) 20 cm × 20 
cm field. The curves were normalised at 9 cm deep and the percentage depth dose applied 
in order to retain the dose relative to dmax.  
 
 
In recent years there have been numerous discussions on using elliptical sources 
for MC models (Huang et al. 2005, Kim 2009). However, as very good agreement 
between MC simulation and measurement was obtained it was not felt that this 
warranted investigation (figures 3.3 to 3.6 show profiles plotted in the y direction, 
and figures 3.11 and 3.12 in section 3.2 show profiles plotted in the x direction). 
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Additionally, although the focus of the paper by Kim (2009) is elliptical sources, 
they find a symmetric source of 0.2 mm to be the best match for their Varian 21EX 
linac. 
 
     
Figure 3.4. Y direction profiles demonstrating the agreement between MC and 
measurement for the 10 MV MC model, 0.5 cm voxels A) 10 cm × 10 cm and B) 5 cm × 5 
cm field. The curves were normalised at 9 cm deep and the percentage depth dose applied 
in order to retain the dose relative to dmax.  
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Figures 3.5 and 3.6 show profiles plotted for the 6 MV model, the primary electron 
energy and electron beam width being set at 6.0 MeV and 0.1 cm respectively.  
 
Figure 3.5. Y direction profiles demonstrating the agreement between MC and 
measurement for the 6 MV MC model, 0.2 cm voxels A) 20 cm × 20 cm and B) 10 cm × 10 
cm field. The curves were normalised at 9 cm deep and the percentage depth dose applied 
in order to retain the dose relative to dmax.  
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Figure 3.6. Y direction profiles demonstrating the agreement between MC and 
measurement for the 6 MV MC model, 0.2 cm voxels, 5 cm × 5 cm field. The curves were 
normalised at 9 cm deep and the percentage depth dose applied in order to retain the 
dose relative to dmax.  
 
 
The optimum photon splitting number for our linear accelerator model (using a 
linear accelerator source) was found to lie between 75 and 100 (figure 3.7), 
efficiency being calculated using equation 3.1. Efficiency was improved by a factor 
of almost 10.5 for splitting numbers of both 75 and 100 when compared to 
simulations with no splitting. A splitting value of 100 is currenly used in all MC 
simulations. 
 
 
Figure 3.7. Normalised efficiency versus photon splitting number used in simulations. 
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Figures 3.8 and 3.9 demonstrate the agreement between MC generated field size 
output factors with and without the correction for backscattered radiation to the 
monitor chamber, using the method devised by Liu et al. 2000. It can be seen that 
inclusion of this correction greatly improved agreement between MC generated 
field size output factors and measurement, both at 6 MV and 10 MV. Correction 
factors, normalised to a (10 x 10) cm2 field, varied from 0.99 for a (5 x 5) cm2 to 
1.013 for a (20 x 20) cm2 field. 
 
Figure 3.8. MC generated field size factors versus measurement, with and without 
correction for backscattered radiation to the monitor chamber at 6 MV. 
 
 
Figure 3.9. MC generated field size factors versus measurement, with and without 
correction for backscattered radiation to the monitor chamber at 10 MV. 
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3.1.4 Discussion 
Experimental data presented here were measured in a water tank, depth dose 
measurements with a Scanditronix RK chamber and profile measurements with a 
Scanditronix photon diode. Before matching a MC model of a linac to acquired 
data, the validity of the measured data must be verified. This is because 
experimental set-up and corrections for the effective point of measurement of the 
chamber make a critical difference, especially in the build up region.  
 
The profile and depth dose plots show there to be very good agreement between 
measurement and MC simulation, both at 6 and 10 MV (see figures 3.1 and 3.3 to 
3.6). The linac models were identical with the exception of the initial electron 
energy, source size and composition and design of the flattening filter and target. 
A photon splitting number between 75 and 100 was found to be the optimum for 
our linac configuration. 
 
3.2 Monte Carlo Modelling of the Multi-Leaf Collimator 
3.2.1 Introduction 
To enable the verification of IMRT fields, a MC model of the Varian 120 leaf 
Millennium MLC was required. The Millennium 120 leaf MLC (figure 3.10) is an 
updated version of the Millennium 80 leaf MLC with 60 leaves on each bank. The 
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central 20 leaves on each bank are 0.5 cm wide (projected to isocentre distance), 
with 10 × 1 cm wide leaves either side of these central leaves. This model of MLC 
therefore allows for finer mod
sizes very rarely being much larger than this. 
 
When the Millennium MLC 
within BEAMnrc (Heath 
simulations in ‘static’ mode. More recently the option to run simulations 
and shoot’ mode has been released enabling multiple segment IMRT beams to be 
simulated in a single simulation
the probability of each segment being simulated
 
Figure 3.10: Varian 120 leaf Millennium MLC, the central 40 leaves on each bank being 
narrower than the outer 10 leaves 
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ulation within the central (20 × 20) cm2
 
DYNVMLC component module was initially 
and Seuntjens 2003), the only option was to run 
, random number generators being used to sample 
 based on the segment weight
 
at each end (image courtesy of Varian). 
 
, IMRT field 
released 
in ‘step 
. 
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3.2.2 Methods 
 
The MLC was fully modelled using the DYNVMLC component module (Heath and 
Seuntjens 2003). This component model includes details such as the leaf driving 
screw hole, support railing groove and leaf tips. Heath and Seuntjens compared 
interleaf leakage profiles for this CM and an equivalent leaf model using the older 
VARMLC CM and demonstrated that the simplified geometry of VARMLC is not 
able to predict the details of the MLC leakage accurately for the 120 leaf 
collimator.  
 
For IMRT treatments with many segments, leaf transmission and leaf inter-leaf 
leakage become important factors in patient dose calculations. In IMRT a 
significant fraction of dose to critical structures is due to radiation scattered from, 
or transmitted through, the MLC (Mohan et al. 2000, Kim et al. 2001). In addition, 
leaf position accuracy is paramount (Budgell et al. 2000). Therefore, during 
commissioning of an MLC, leaf transmission, inter-leaf leakage, leaf abutment 
leakage and leaf position are all significant factors that must be verified. The field 
shape in figure 3.11 and 3.12 enables verification of rounded leaf end position and 
leaf transmission relative to the open field dose. The closed field shape shown in 
figure 3.13 was used to verify both inter-leaf leakage and leaf end abutment 
leakage. Additionally, the density of tungsten in the simulations was modified as 
previous work at our centre (Spezi 2003) found that this was necessary for the 
older 80 leaf MLC.  
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 3.2.3 Results and Discussion 
As with previous work carried out at our centre (Spezi 2003) good agreement 
between simulation and measurement was found with a tungsten density of 17.5 
g/cm3. When the standard ICRU tungsten density was used leaf transmission was 
underestimated by about 4%. Figures 3.11 and 3.12 demonstrate the efficient 
modelling of the rounded leaf ends and the dose under the MLCs relative to the 
open field dose. Figure 3.13 demonstrates the ability of the MC MLC to model the 
leakage between abutting MLC leaves and inter-leaf leakage. The maximum 
measured inter-leaf leakage was 2.3%, compared to a maximum simulated value 
of 2.4%.  It can also be seen from figure 3.13 that there is large variation in 
measured leakage for different leaves, due to very slight physical differences in 
reality, and so exact modelling would not be possible without tediously re-writing 
the whole component module for every individual MLC. 
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Figure 3.11. Profile cuts across a diamond shaped field to demonstrate agreement of leaf 
transmission between MC and measurement at 10 MV. 
A 
B 
C 
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Figure 3.12. Profile cuts across a diamond shaped field to demonstrate agreement of leaf 
transmission between MC and measurement at 6 MV. 
 
A 
B 
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Figure 3.13. Profile cuts across 10 MV beam with closed MLCs, dose being expressed as a 
percentage of the open field dose. A) Profile cut in x direction. Dose at the leaf abutment 
position was found to be 25% of the open field dose. B) Profile cut in y direction under 
MLCs. Maximum inter-leaf leakage for the MC model was found to be 2.4%, comparing 
well with the measured value of 2.3%. It can be seen that there is large variation in 
measured leakage for different leaves. 
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Chapter 4 
 Monte Carlo Modelling of EPID 
 
4.1 Introduction 
As stated in the introduction, there are a number of EPID dosimetry approaches 
published in the literature, both pre-treatment to verify delivery before treatment 
commences and transit dosimetry to verify delivery during treatment of the 
patient. Most portal dosimetry techniques employ either empirical methods (with 
correction factors applied for non-water equivalence (Nicolini et al. 2006)) or 
superposition / convolution methods (with kernels derived either from extensive 
measurements (Chen et al. 2006, Wendling et al. 2006) or MC simulation 
(McCurdy et al. 2001, Warkentin et al. 2003, Steciw et al. 2005, Li et al. 2006)).  
 
At our centre we have for several years been developing approaches involving full 
forward MC calculation of portal dose (Spezi and Lewis 2002, Chin et al. 2004, 
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Chin et al. 2005) along with some centres elsewhere (Siebers et al. 2004, Parent et 
al. 2006, Parent et al. 2007). A detailed MC model of the linac, in combination with 
the EPID, enables the dose to the detector to be predicted accurately, without the 
need for scatter approximations or conversion to dose in water, achieving 
versatility difficult to accomplish by any other technique. 
 
The main components common to modern a-Si EPIDs are (i) the (typically 1 mm 
thick) copper plate, which converts photons to high energy electrons and absorbs 
low energy scatter (ii) the terbium doped gadolinium oxysulphide (Gd2O2S:Tb) 
scintillating screen, which converts electrons to optical photons (iii) the a-Si 
photodiodes, which detect the optical photons (iv) the thin-film transistors within 
a glass substrate that store an amount of charge that is proportional to the amount 
of light received by the photodiode. An ideal detector would be water equivalent 
(as this is the reference medium for radiation dosimetry) but the high atomic 
number components present in these EPIDs prevent them from being 
approximated accurately by a water model.  
 
As well as accurately modelling radiation transport from the linac to the EPID it is 
important to take account of other factors which contribute to the overall 
accuracy of the result. Two aspects in particular are considered in this work. 
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1) Backscatter into the radiation-sensitive layer of the detector from ancillary 
components such as support arm and cabling. This is particularly 
important when IMRT fields cover a large proportion of the active area of 
the EPID, which is the case for all IMRT plans currently delivered at our 
centre. 
2) The linearity of EPID response with dose for different dose-rates, as there 
is a requirement to deliver treatments at the highest possible dose rates to 
facilitate throughput. 
 
The Varian imager considered in this work has a support arm which has been 
reported to cause difficulties in portal dosimetry, primarily in the inline direction, 
due to non-uniform backscatter from supporting structures (Siebers et al. 2004, 
Ko et al. 2004, Moore and Siebers 2005, Greer et al. 2009, Wang et al. 2009, Cufflin 
et al. 2010a). Various solutions to this issue have been presented in the literature. 
Ko et al. (2004) suggested adding material downstream of the EPID phosphor to 
make the backscatter being detected more uniform, and Greer et al. (2009) 
devised a method to remove the backscatter component from the pixel sensitivity 
flood field correction matrix, retaining only field specific backscatter in the 
images. The solution proposed, as set out below, is to incorporate in an 
approximate way the backscattering components into the MC model of the EPID 
itself.  Figure 4.1 shows a schematic diagram of the linac and EPID with supporting 
structures and figure 4.2 shows images of the EPID and supporting structures. 
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Dose-rate dependent EPID saturation effects have been reported previously in the 
literature (van Esch 2004). Also, IMRT overshoot and undershoot delivery errors 
from certain linacs are known to increase with dose-rate (Ezzell and Chungbin 
2001, Grigorov et al. 2006, Kuperman and Lam 2006). These effects have been 
verified using a combination of ionisation and film dosimetry. With the desire to 
move to higher dose delivery rates to facilitate patient throughput, the ability of 
any dosemeter to detect dose-rate dependent treatment effects is paramount.  
 
 
Figure 4.1. Schematric diagram of Varian linac and EPID with supporting structures. 
 
 
              
Figure 4.2. Images of the EPID and supporting structures. 
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4.2 Methods 
This work was carried out on a Varian 2100CD linear accelerator with aS500 EPID 
on an 'Exact' arm. The BEAMnrc MC code (Rogers et al. 1995) was used to model 
the linac and DOSXYZnrc (Walters et al. 1996) to model the a-Si detector. Cross 
section dataset ICRU 521 was selected, corresponding to thresholds of secondary 
electron production of 10 keV, based on material compositions and densities set 
out in ICRU Report 37 (1984). ECUT and PCUT were set to 0.7 MeV and 0.01 MeV 
respectively for linac simulations. DBS was used to increase calculation efficiency 
(see Chapter 2), with a splitting number of 1000. All simulations were corrected 
for backscatter to the monitor chamber by the method described by Liu et al. 
(2000).  
 
The DOSXYZnrc grid size in the X-Y plane was set to (2 × 2) mm2 to decrease the 
run-time of the simulations (the photodiode spacing being 0.784 mm), with 
varying dimensions in the Z direction based on the vendor data supplied. This 
resulted in some loss of imager resolution, but as the imager was positioned at 
140 cm source to detector distance (SDD) this corresponds to an effective pixel 
side of 1.4 mm at isocentre. For the detector simulations ECUT was set to 0.7 MeV 
as no significant difference was found between results with ECUT set to 0.521 MeV 
and 0.7 MeV, with 0.7 MeV offering a time saving factor of 1.6. PCUT was set to 
0.01 MeV and so optical processes (conversion to light, transport of optical 
photons from the scintillator to the photodiodes and photodiode signals) were not 
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simulated, but as the photodiode signals are proportional to the energy deposited 
in the phosphor screen this is the layer of interest in the simulations. The EXACT 
boundary crossing algorithm was used as this is known to be the most accurate, 
especially where charged particle equilibrium does not exist or where the 
phantom is split into non-uniform voxels (Walters and Kawrakow 2007). For 
calibration simulations requiring low uncertainty, 4 x 107 histories were 
simulated from the source and particles recycled within DOSXYZnrc to obtain 
uncertainties of less than 1%. For IMRT segments 2 x 107 histories were simulated 
from the source and particles recycled within DOSXYZnrc to achieve uncertainties 
of less than 2%.   
 
The aS500 EPID has 512 × 384 pixels of 0.784 x 0.784 mm2. The hardware version 
was IAS2 equipped with software version 6.1.11. The imager was set up for 
continual acquisition for all measurements (‘IMRT Mode’ with no pulse 
synchronisation). The signal generated by the incident photons is stored by the 
thin-film transistors until it is read out and digitised through an analogue to digital 
converter. Each of the 384 rows is scanned in sequence by the read-out 
electronics, 384 rows comprising an image ‘frame’.  
 
In this work the imager was positioned at 140 cm SDD for all measurements to 
minimise the saturation effect observed by others at higher dose rates and shorter 
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SDDs (van Esch et al. 2004), but also with the progression to transit dosimetry in 
mind. The standard Varian EPID calibration procedure was employed (equation 
4.1).   
FFmeankImage Field Flood
Image FieldDark  - Image Portal
  Image Portal Corrected ×=  (4.1) 
where kFFmean is the mean pixel value for the flood field image. The dark field 
image is acquired with the radiation off and accounts for any electrical leakage 
and the flood field image is acquired with the radiation covering the detector area 
and corrects for individual cell sensitivities and electrometer gains.  
 
4.2.1 Backscatter Modelling and Calibration 
 
Figure 4.3. Large beam profile in water with beam ‘horns’ and large beam profile for an 
EPID image demonstrating the removal of the beam ‘horns’ by the standard Varian flood 
field calibration procedure. 
 
The standard ‘flood field’ correction described above results in uniform ‘flattened’ 
images in which the beam ‘horns’ are removed (figure 4.3). This situation is easy 
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to replicate for large symmetric fields by similarly dividing MC simulated images 
by a MC-generated flood image of the same size as the acquired flood image. 
However, the situation becomes far more complex for small fields or segments off- 
axis in the inline direction for which the scattering conditions become very 
different to the flood field situation. For example, for two (3 x 3) cm2 beams 
centred at ± 6 cm off-axis, the non-uniform backscatter effect results in a 4% 
difference in image intensity (figure 4.4). 
 
Initial simulations were carried out with a uniform slab of water equivalent 
material of thickness 2 cm to represent the backscattering material. This thickness 
was chosen because simulated and measured field size output factors (FSFs) 
agreed to within ± 1% on the central axis for the range of field sizes typically used 
(from (2 x 2) cm2 to (20 x 20) cm2). The solution devised to correct for non-
uniform backscatter from the supporting structures involved adding water 
equivalent material to the back of the DOSXYZnrc EPID model and varying the 
thickness of material at every position until the simulated ‘flood’ images matched 
the acquired flood images, maximum differences at any position being within ± 
2% over the entire imager area (ignoring any defective pixels). Figure 4.8 in the 
results section demonstrates the match of the acquired to MC generated flood 
images.   
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Figure 4.4. Profile cut through seven linearly aligned (3 x 3) cm2 fields to demonstrate 
the effect of non-uniform scatter from EPID components on the intensity of small fields 
centred at different positions on the device. 
 
The MC portal verification procedure was initially commissioned for simple, non-
IMRT, symmetric fields of various sizes from (2 x 2) cm2 to (20 x 20) cm2 and 
delivered monitor units (MU) of 10 to 100 MU. Calibration curves converting MC 
dose to portal image pixel intensity were obtained for this MU range for a (10 x 
10) cm2 field at 100, 300 and 600 MU since the pulse repetition rates for these 
three dose rates are constant (see figure 4.5). Although a-Si EPIDs are reported to 
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demonstrate reasonable response stability over time (Louwe et al. 2004, Budgell 
et al. 2007), two of the EPIDs at VCC are refurbished panels. Therefore regular 
image calibration is routine and a quick (10 × 10) cm2 dosimetric calibration is 
performed in every week that dosimetric measurements are to be made. This 
weekly dosimetric calibration is consistent for all EPID work reported in this 
thesis.  
 
To test the robustness of the MC model with devised backscatter solution, off-axis 
images of different field sizes were also evaluated. Figure 4.6 illustrates three (5 × 
5) cm2 images and three (2 × 2) cm2 images at different positions in the inline 
direction to test the backscatter solution for off-axis small fields. These fields were 
created using the Varian ‘Shaper’ software and the collimator was rotated to 90°. 
 
As unclean discharge and charge trapping, referred to as ‘ghosting’ and ‘image lag’, 
have been reported for a-Si EPIDs (van Esch 2004, McDermott et al. 2006a), a 
straightforward comparison of the magnitude of these effects at the three dose-
rates being investigated was performed. A 5 MU (10 x 10) cm2 irradiation was 
carried out immediately following a 100 MU (5 x 5) cm2 irradiation and the 
increase in signal at the centre of the image was evaluated. In addition, McDermott 
et al. (2006a) reported non-linearity of system response due to image lag at low 
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doses, and so the linearity of EPID response was evaluated for an extended range 
of MU from 5 MU to 500 MU at the two lower dose-rates of 100 and 300 MU min-1. 
 
Figure 4.5. Varian Clinac Pulse Patterns. 
 
                
Figure 4.6. The location of A) three (5 × 5) cm2 images and B) three (2 × 2) cm2 images at 
different positions in the inline direction to test the robustness of the backscatter 
solution. 
 
4.3 Results 
The final EPID model (illustrated in figure 4.7) is composed of 28 layers of 
different materials based on data supplied by the vendor plus 4 additional non-
uniform layers of water equivalent material (and air) to represent the differential 
backscatter.  The solution found to minimise differences between simulation and 
measurement in the flood field data (as shown in figure 4.8) was asymmetric in 
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both directions to represent the various components such as the imager support 
arm and cabling. The maximum thickness of water equivalent material was 5.5 cm 
to represent the imager arm, there being 5 cm backscattering material at the 
central axis. Although from figure 4.2 it can be seen that there is some additional 
wiring and casing to one side of the imager in the crossline direction, it is possible 
that the crossline asymmetry measured could be due to slight beam asymmetry, 
which would be very difficult to determine using this method without a rotation of 
the imager. However, as the magnitude of the crossline asymmetry (1%) is very 
much less than that in the inline direction (5%) the effect on the final results is 
negligible.  
 
Figure 4.9 shows that the portal image calibration curves obtained at 100 MU 
min−1 and 300 MU min-1 were collinear in the range 10 MU to 100 MU to within 
0.3% (0.3% being the maximum deviation from the line of best fit). In addition, 
figure 4.10 demonstrates the linearity of EPID response for the extended range of 
5 MU to 500 MU (to within 0.8%) at 300 MU min-1. The non-linearity at lower 
dose-rates reported by McDermott et al. 2006a was not observed on any of our 
Varian aS500 EPIDs. The ‘kink’ visible in the calibration curve for 600 MU min-1 
(figure 4.9), corresponding to a loss of approximately 1 MU, occurs due to the 
transfer of the frame buffer to the CPU after the 64th frame, resulting in saturation 
of the 65th frame which appears longer as a result. (The vendor has informed us 
that upgrading to an IAS3 system eliminates these saturation effects due to the 
faster read-out of up to 30 frames per second compared with the maximum read-
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out of 15 frames per second with the IAS2 system). Although this loss of signal 
only corresponds to 1.5% for 65 MU, it becomes particularly significant for 
acquisitions where the 65th frame occurs during a low MU segment. For example, 
for an 8 MU segment this would correspond to 12.5% ‘missing dose’. No decrease 
in signal caused by saturation of the 65th frame is visible for the 100 and 300 MU 
min-1 irradiations.  
 
Figure 4.7. Cross-sections of the DOSXYZnrc imager model including ‘supporting 
structures’. 
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Figure 4.8. The matching of the MC simulated flood images to acquired flood images. The 
isolated low intensity values are due to defective imager pixels. 
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Figure 4.9. Portal Image Pixel Intensity versus MC dose and delivered MU for 100, 300 
and 600 MU min-1 up to 100 MU. 
 
 
 
Figure 4.10. Linearity of EPID response for 300 MU min-1 for extended dose range from 5 
MU to 500 MU. 
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The investigation into ghosting and image lag showed the effect to be similar at all 
3 dose rates as depicted in figure 4.11. For the situation investigated, a 5MU (10 x 
10) cm2 image immediately following a 100 MU (5 x 5) cm2 image, there was an 
increase in detector signal of the central pixels of 1.6% for all three dose-rates 
investigated. However, this increase corresponds to just 0.08 MU and as typical 
beam MU are much greater than 5MU, the percentage error would be very much 
less than 1.6% in practice. 
 
The methods described in this chapter account for the effects of the differential 
backscatter for all field sizes both on and off-axis. It should be possible to extend 
this method to all EPID positional set-ups, although this has not been verified in 
this work. Measured versus simulated FSFs at the central axis are given in table 
4.1. The approach correctly predicted electronic portal image greyscales for 
simple, non-IMRT fields to within ± 1% on the central axis. It can be seen from 
figure 4.12 A-D that for symmetric fields on the central axis there is very little 
difference in results with and without the devised solution for backscatter. 
However, for small off-axis fields there is very good agreement between MC and 
acquired image when taking the differential backscatter solution into account 
(within 1% for all fields), but a discrepancy of over 3% is visible for the small (2 × 
2) cm2 field off-set in the target direction when using 2 cm uniform backscatter in 
simulations. 
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Figure 4.11 The effects of ghosting for a 5MU (10 x 10) cm2 image immediately following 
a 100 MU (5 x 5) cm2 image. A) 100 MU min-1 B) 300 MU min-1 and C) 600 MU min-1. 
 
 
 
 
Field Size 
(cm2) 
Measured 
EPID FSFs  
1 cm uniform 
backscatter 
2 cm uniform 
backscatter 
Non-uniform 
backscatter 
solution  
FSF Percentage 
Difference 
FSF Percentage 
Difference 
FSF Percentage 
Difference 
(2 × 2) 1.205 1.178 -2.2% 1.197 -0.7% 1.195 -0.8% 
(5 × 5)  1.096 1.075 - 1.9% 1.087 - 0.7% 1.093 - 0.3% 
(10 × 10)  1.000 1.000 - 1.000 - 1.000 - 
(20 × 20)  0.914 0.928 +1.5% 0.923 +1.0% 0.923 +1.0% 
Table 4.1. Measured EPID versus MC simulated FSFs for different backscatter conditions 
in simulations. Simulated FSFs were calculated for the central (5 × 5) voxels of (0.2 × 0.2) 
cm2, uncertainties being less than 2% per voxel. 
 
A 
B C 
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Figure 4.12. Inline profiles with and without the backscatter solution delivered in 
standard (non-IMRT) mode at a dose-rate of 300 MU min-1. A) (15 × 15) cm2 field with 2 
cm uniform backscatter B) (15 × 15) cm2 field with devised backscatter solution included 
C) 3 × (2 × 2) cm2 fields with 2 cm uniform backscatter D) 3 × (2 × 2) cm2 fields with 
devised backscatter solution included.  
 
 
4.4 Discussion 
The results obtained in this work are published in part by Cufflin et al. (2010a). 
The modelling solution devised to correct for non-uniform backscatter to the 
imager from the supporting structures is relatively simple yet has proved effective 
for all field sizes both on and off-axis, the results of MC IMRT simulations being 
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presented in the next chapter. Additionally, EPID response was found to be linear 
with dose at in the range 5 to 500 MU at dose-rates of 100 and 300 MU min-1. A 
loss of approximately 1 MU was observed due to saturation of the 65th frame at 
600 MU min-1, although a fix for this problem is reportedly available with an 
upgrade from the vendor. It is anticipated that the response would be linear at all 
dose-rates for upgraded systems. 
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Chapter 5 
Pre-treatment Monte Carlo EPID 
Dosimetry for IMRT Verification 
 
5.1 Introduction 
This aspect of the thesis investigates the accuracy of MC simulations of amorphous 
silicon (a-Si) EPIDs for the dosimetric verification of IMRT prior to treatment. In 
particular, the suitability of the method for verification of head and neck IMRT 
with extended field segments (≈ 20 cm superior-inferior) covering almost the 
entire detector area was studied. This work also investigated the sensitivity of the 
technique to dose-rate variations in IMRT delivery. 
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5.2 Methods 
5.2.1 Identification of IMRT Dose-Rate Dependent Delivery Errors 
The imager was set-up to integrate the dose for the treatment beam (by selecting 
integrating or ‘IMRT’ image acquisition mode on the software).  For clinical IMRT 
fields it is not possible to determine exact delivery errors that are present during 
each individual segment due to the complex nature in which multiple IMRT 
segments overlap and random errors being present on all segments (Ezzell and 
Chungbin 2001, Grigorov et al. 2006, Kuperman and Lam 2006). Therefore two 
simple sequences, one consisting of three sequential (2 × 2) cm2 fields and the 
other of three sequential adjacent (5 × 5) cm2 fields (figure 5.1) were created 
using Varian ‘Shaper’ software and delivered both in Varian standard mode (non-
IMRT mode) and in IMRT mode at dose-rates of 100, 300 and 600 MU min-1. The 
collimator was rotated to 90° and 10 MU per (2 × 2) cm2 field or (5 × 5) cm2 field 
was delivered. The EPID was irradiated directly and the same situation was set up 
within DOSXYZnrc for MC simulations. Portal images were acquired 3 times at 
each dose-rate and averaged. Calibration curves converting MC dose to portal 
image pixel intensity were obtained for a (10 x 10) cm2 field and delivered MU of 
10 to 100 MU. Additionally an NE 2571 Farmer-type ionisation chamber (Nuclear 
Enterprises, Berkshire, UK) was positioned at the centre of each (5 × 5) cm2 
segment, 5 cm deep in water equivalent material, as a direct comparison. An SDD 
of 140 cm was maintained to ensure a large enough field size for accurate 
chamber measurements. The measurements were repeated 10 times. 
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Figure 5.1. The simple three segment sequences set up to detect IMRT delivery errors. A) 
three (5 × 5) cm2 segments and B) three (2 × 2) cm2 segments. 
 
5.2.2 Example Head and Neck IMRT Plan 
The example IMRT plan referred to in this study is from a complex, highly 
modulated, head and neck ‘step and shoot’ treatment (figure 5.2) with 3 planning 
target volumes (PTVs) enabling the primary tumour and nodal volumes to be 
treated to different prescriptions of 66 and 54 Gy. The plan was optimised and 
calculated on Oncentra Masterplan (OMP, Nucletron) and consisted of 7 beams, all 
split in two due to restrictions in MLC movement, example EPID images being 
given in figure 5.3. It can be seen from figures 5.2 and 5.3 and table 5.1 that the 
treatment required very large fields (most with 20 cm superior-inferior extent) 
resulting in a large area of the detector being irradiated, meaning that an effective 
solution to the backscatter problem was imperative. The DICOM export facility 
was used to export the plan parameters, for example jaw and MLC positions and 
MU for each segment, and Matlab scripts used to automate creation of BEAMnrc 
input files.  
 
1 
2 
3 
3 
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1 
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5.2.2.1 Evaluation of Results 
All results were processed using Matlab software and analysed using the gamma 
evaluation method (Low et al. 1998). The gamma evaluation method enables 
quantitative comparative analysis of dose distributions. Now in widespread use 
for comparing dose distributions in radiotherapy, the original technique was 
proposed in 1998. The method takes into account both percentage dose difference 
and distance to agreement (DTA) (equation 5.1), both these quantities being given 
levels by which to pass or fail a dose point when two dose distributions are 
compared.   
2
m
cm
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Γ
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+=   (5.1) 
where for each reference point, mr
r
, 
gamma, Γ , is evaluated with respect to the 
calculation point, cr
r
. m∆d is the defined ‘acceptable’ distance to agreement and 
m∆D  the defined ‘acceptable’ dose difference. Finally, )r,rr( cm
rr
is the distance 
mc rr
vr
−  and )r,r( cm2
rr∂  is the dose difference between the dose at the calculation 
point and the dose at the reference point. If the gamma evaluation value for a 
reference point is less than one, then that point has ‘passed’ the evaluation. 
Usually a percentage of points passing or failing is quoted. 
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Gamma analysis was performed for a 20% dose threshold so that the results were 
representative of the area within the treatment field. The percentage of points 
within the field passing gamma criteria of 2% (of maximum dose), 2.8 mm were 
calculated at the detector level of 140 cm SDD and converted back to isocentre 
level.  
 
 
 
Figure 5.2. The complex IMRT plan modelled in this chapter. There are 2 dose levels 
prescribed, the primary PTV being treated to 66 Gy and additional nodal PTVs being 
treated to 54 Gy. 
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EPID Image Intensity 
 
Figure 5.3 EPID images (at 140 cm SDD) for beams 1 to 3. 
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Beam X  (crossline) 
dimension  
(cm) 
Y  (inline) 
dimension 
 (cm) 
Number of 
Segments 
Total Beam 
MU 
1_1 10.5 18.5 4 60 
1_2 10.5 20.0 6 93 
2_1 9.8 20.0 7 71 
2_2 9.1 20.0 5 40 
3_1 9.1 20.0 4 40 
3_2 9.1 20.0 6 66 
4_1 11.2 20.0 6 64 
4_2 10.5 20.0 6 73 
5_1 10.5 20.0 8 69 
5_2 10.5 19.5 4 23 
6_1 8.4 19.5 6 59 
6_2 8.4 19.5 6 50 
7_1 10.5 19.5 6 71 
7_2 9.8 19.5 6 68 
Table 5.1. IMRT Plan Information. 
 
5.3 Results 
5.3.1 Identification of IMRT Delivery Errors 
Figure 5.4 A - D shows the comparison between MC simulation and acquired 
image when delivering the (2 × 2) cm2 sequence in figure 5.1 in both standard 
(non-IMRT) and IMRT mode at a dose-rate of 300 MU min-1. C and D demonstrate 
the ability of the MC EPID dosimetry technique to detect the systematic overdose 
on the first segment and systematic underdose on the final segment for IMRT 
deliveries, these errors being of the order of 0.3 MU at 300 MU min-1. These 
delivery errors increase with dose-rate and are not present for standard, non-
IMRT deliveries. The delivery errors were found to be very similar for both sets of 
sequences illustrated in figure 5.1, the (2 × 2) cm2 sequence being shown in figure 
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5.4 to demonstrate the combination of dose-rate plus backscatter effects, the 
backscatter effects being greater the smaller the field size. These results were 
verified by ion chamber measurements, agreement between EPID images and 
chamber measurement being within 0.1 MU (or 1%) for the 10 MU per segment 
deliveries (1% being the uncertainty on these simulations). Average undershoot 
and overshoot delivery errors measured by ion chamber were of approximately 
0.1 MU, 0.3 MU and 0.6 MU at 100, 300 and 600 MU min-1 respectively. 
Additionally, random delivery errors, also increasing with increasing dose-rate, 
were measured on intermediate segments. 
 
The delivery errors observed are understood to be due to the finite sampling time 
of the MLC controller. This effect has been observed previously using other 
methods (Ezzell and Chungbin 2001, Grigorov et al. 2006, Kuperman and Lam 
2006). Irradiation of all segments is initiated by the MLC controller when the 
leaves are within tolerance (1 mm), but the MLC controller only receives 
information on delivered MU approximately every 50 ms, resulting in the 
delivered MU being different to the planned MU. The total beam cumulative MUs 
are, as for standard deliveries, monitored and controlled by the monitor ionisation 
chambers and so if too many MU have been delivered at the start of the final 
segment, this will result in an underdose on this segment.  
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Figure 5.4. Inline profiles with and without the backscatter solution delivered in both 
standard (non-IMRT) and IMRT mode at a dose-rate of 300 MU min-1. A) 3 × (2 × 2) cm2 
standard delivery fields with 2 cm uniform backscatter B) 3 ×  (2 × 2) cm2 standard 
delivery fields with devised backscatter solution included C) 3 × (2 × 2) cm2 IMRT 
delivery fields with 2 cm uniform backscatter D) 3 ×  (2 × 2) cm2 IMRT delivery fields with 
devised backscatter solution included. C and D demonstrate the ability of the technique to 
detect overshoot and undershoot delivery errors on the first and last segments 
respectively. 
 
 Segment 1 Segment 2 Segment 3 
100 MU min-1 +0.11 MU  
(σ 0.02 MU) 
-0.01 MU  
(σ 0.01 MU) 
-0.10 MU  
(σ 0.01 MU) 
300 MU min-1 +0.33 MU  
(σ 0.06 MU) 
+0.11 MU  
(σ 0.05 MU) 
-0.30 MU  
(σ 0.06 MU) 
600 MU min-1 +0.67 MU  
(σ 0.09 MU) 
+0.15 MU  
(σ 0.19 MU) 
-0.59 MU 
(σ 0.08 MU) 
Table 5.2. Average IMRT dose delivery errors with associated standard deviation, σ, 
measured with ionisation chamber. 
A B 
C D 
Segment 1 
0.3 MU 
overdose 
 
Segment 3 
0.3 MU 
underdose 
 
Segment  1 
0.3 MU 
overdose 
Segment  3 
0.3 MU 
underdose 
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5.3.2 Example Head and Neck IMRT Plan 
For the head and neck IMRT plan an average of 96% of points passed gamma 
criteria of 2%, 2 mm (at isocentre) at a dose-rate of 100 MU min-1 with the 
backscatter solution included, compared to an average of 79% of points passing 
this gamma criteria without the correction included (see detailed results in table 
5.3). Figure 5.5 shows the improvement in image intensity prediction for a beam 
with a small off-axis segment (beam 3_1) when the backscatter effect is included. 
 
  2%, 2.8 mm at 140 cm 
SDD 
3%, 4.2 mm at 140 cm 
SDD 
Beam Total 
MU 
With 
backscatter 
correction 
Without 
backscatter 
correction 
With 
backscatter 
correction 
Without 
backscatter 
correction 
1_1 60 94.9 81.9 99.6 99.3 
1_2 93 96.2 78.0 99.9 98.0 
2_1 71 97.6 75.5 99.9 96.2 
2_2 40 95.5 91.8 100.0 99.6 
3_1 40 95.2 80.5 99.5 91.1 
3_2 66 96.2 65.8 99.6 91.2 
4_1 64 98.1 79.2 100.0 98.6 
4_2 73 94.4 68.3 99.6 91.6 
5_1 69 96.4 84.1 99.9 99.4 
5_2 23 88.4 80.7 98.5 97.9 
6_1 59 96.7 90.0 99.9 99.7 
6_2 50 97.9 78.5 99.7 98.5 
7_1 71 96.5 71.7 99.5 96.6 
7_2 68 96.4 73.9 99.7 97.5 
      
Average  95.7 78.6 99.7 96.8 
σ  2.5 7.4 0.4 3.2 
Table 5.3 Percentage of points passing gamma criteria of 2%, 2.8 mm and 3%, 4.2 mm 
with and without the devised correction for non-uniform backscatter. The standard 
deviation, σ, is also given. All images were acquired at 100 MU min-1, the most accurate 
delivery.  
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Figure 5.5. Demonstrating the effect of the established correction for backscatter for 
beams with small off- axis segments (beam 3_1 is shown in the figure).  A) Without 
backscatter correction included. B) With backscatter correction included.  
 
Irradiating all IMRT fields at dose-rates of 100 and 300 MU min-1 clearly 
demonstrated the ability of the technique to detect dose delivery errors. For all 
images, there is much better agreement between acquired image and prediction at 
100 MU min-1 than at 300 MU min-1, an average of 96% and 92% of points pass 
A B 
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gamma criteria of 2%, 2 mm (at isocentre) at a dose-rate of 100 and 300  MU min-1 
respectively (see summary in table 5.4).  In addition, the areas exposed to both the 
first and final segments consistently showed low dose differences due to the 
overshoot and undershoot effects cancelling out, average dose differences for 
these areas all being within 1.5% local dose for the 100 MU min-1 acquisitions and 
2.5% local dose for the 300 MU min-1 acquisitions. In all cases the first segment 
covered a much greater area than the final segment and areas of overdose can be 
seen within areas exposed during the first segment but not the final segment. 
Figure 5.6 shows the percentage difference between acquired image and MC 
prediction for beam1_1, as an example of the results obtained. It can be seen that 
the difference between MC prediction and measurement is low for the area of 
overlap between the first and last segments.  
 
600 MU min-1 deliveries showed greater discrepancies but detailed results have 
not been included due to the saturation of the 65th frame being unpredictable for 
IMRT deliveries.  For all situations the lowest percentage of points passing the 
gamma criteria was for beam 5_2, this beam consisting of only 23 MU in total (4 
segments of 5.1, 4.3, 1.3 and 12.3 MU) and so sub-MU dose delivery errors are a 
large percentage of each segment MU. 
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  2%, 2.8 mm at 140 cm 
SDD 
3%, 4.2 mm at 140 cm 
SDD 
Beam Total MU 100 MU 
min-1 
300 MU 
min-1 
100 MU 
min-1 
300 MU 
min-1 
1_1 60 94.9 92.2 99.6 99.5 
1_2 93 96.2 94.5 99.9  99.9 
2_1 71 97.6 89.3 99.9 99.7 
2_2 40 95.5 96.1 100.0 99.9 
3_1 40 95.2 93.1 99.5 99.4 
3_2 66 96.2 95.5 99.6 99.6 
4_1 64 98.1 97.8 100.0 100.0 
4_2 73 94.4 84.1 99.6 98.9 
5_1 69 96.4 96.1 99.9 99.7 
5_2 23 88.4 80.5 98.5 95.9 
6_1 59 96.7 90.6 99.9 99.8 
6_2 50 97.9 89.1 99.7 98.5 
7_1 71 96.5 94.3 99.5 99.6 
7_2 68 96.4 92.7 99.7 99.6 
      
Average  95.7 91.9 99.7 99.3 
σ  2.4 4.8 0.4 1.1 
Table 5.4 Percentage of points passing gamma criteria of 2%, 2.8 mm and 3%, 4.2 mm at 
100 and 300 MU min-1. The standard deviation, σ, is also given. 
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Figure 5.6. Beam 1_1 (60 MU, 4 segments). A-D) The beam segments in order, E) 
Percentage difference between acquired image and MC prediction at 100 MU min−1, F) 
Percentage difference between acquired image and MC prediction at 300 MU min-1.  
NB The area outside the beam has been excluded from the calculation and therefore 
should not be interpreted according to the colour scale. 
 
 
5.4 Discussion and Conclusions 
The results obtained in this work were reported in Cufflin et al. (2010a) and 
presented, in part, at the international Electronic Portal Imaging conference in San 
Francisco in 2008, EPI2k8 (Cufflin et al. 2008). They show Monte Carlo portal 
dosimetry to be a particularly accurate IMRT verification technique. The 
modelling solution devised to correct for non-uniform backscatter to the imager 
from the supporting structures enables the verification of large IMRT beams 
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covering almost the entire detector area. The IMRT verification results using MC 
portal dosimetry are excellent, with an average of 96% of pixels passing gamma 
criteria of 2%, 2 mm at isocentre at 100 MU min-1 with the devised correction for 
backscatter included. 
 
Additionally this investigation has shown MC to be accurate enough to detect real, 
sub-MU delivery errors, the magnitude of these errors being consistent with 
previously published data derived by other methods (Ezzell and Chungbin 2001, 
Grigorov et al. 2006, Kuperman and Lam 2006). Additional random errors on any 
overlapping intermediate segments may increase the magnitude of the overall 
error per beam. Although these sub-MU errors are unlikely to be significant 
individually, delivery errors on multiple beams incident on the same volume of 
tissue will have a cumulative effect. These errors may be a significant percentage 
of low dose regions within IMRT treatment fields, which often correspond to 
organs at risk such as the spinal cord or rectum. Grigorov et al. 2006 show an 
example where approximately 30% of the rectal volume received an increase in 
dose due to the overshoot effect. They reported an average increase in rectum 
mean dose of 0.5 Gy and 2-3% NTCP for the ‘overshoot’ dose inaccuracy. Similarly, 
if multiple last segments are incident on the same voxels, a cold spot in the PTV 
may result. Along with the demonstrated pre-treatment solution to the 
verification of IMRT, chapter 8 describes the development and application of the 
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technique to the verification of delivery during treatment (transit dosimetry) 
without intrinsic reduction in accuracy. 
 
Initially the main drawback of this technique was that it was time consuming, 
single segments taking several hours to simulate on the cluster of 30 processors 
described above. However, distributing simulations on the recently developed 
RTGRID service (Chapter2, Downes et al. 2009) enables more rapid (and therefore 
more routinely usable) calculations.  
 
This work demonstrates the sensitivity and accuracy of MC portal dosimetry for 
absolute verification purposes and fields of arbitrary complexity. The technique 
will enable testing of methodologies put in place to correct for delivery errors, 
such as those described by Grigorov et al. (2006) and Kuperman and Lam (2006) 
and can also aid in the selection of the best delivery parameters for IMRT 
treatments. 
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Chapter 6 
INtegrated TReatment Planning and EPID 
Dosimetry (INTREPID):  Devised Method 
and Novel Correction for Non-Uniform 
Backscatter 
 
6.1 Introduction 
Although it is widely accepted that MC simulations provide the most accurate 
method of radiotherapy dose calculation, they are inevitably time consuming. 
Even with increased computing power this issue continues to restrict the 
widespread use of MC simulations clinically.  For this reason this work has 
investigated an alternative method for clinical verification of IMRT plans using an 
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EPID. The method devised as a part of this work is accurate, efficient and cost 
effective. Doses delivered by the IMRT plan for a given patient are calculated in a 
water-equivalent phantom at the EPID position of 140 cm SDD on the TPS 
currently used for all clinical radiotherapy planning. The dose ‘maps’ are 
converted to EPID image intensity using a set of pre-calculated correction factors 
provided from MC simulations and measurement. The technique has the 
advantage that it utilises the TPS and algorithm that the patient plan was based 
upon. The developed MC pre-treatment method (chapter 5) verifies the treatment 
delivery only, separate MC simulations in water or using patient CT data being 
needed to verify the TPS dose calculation. 
 
Additionally, the difficulties in dosimetry caused by non-uniform backscatter from 
the imager arm (the effects of which are discussed in detail in chapter 4) had to be 
approached differently. A novel and versatile solution was found, which can be 
applied to all EPID dosimetry systems regardless of dose calculation methods 
used. 
 
6.2 Method 
As with all EPID work described in this thesis, calculations and measurements 
were carried out on a Varian 2100 CD linear accelerator with aS500 EPID at 140 
cm SDD. IMRT irradiations were carried out at a dose-rate of 300 MU min-1. As 
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previously discussed in Chapter 5, there are known systematic delivery errors 
averaging 0.3 MUs for the first and last segment at this dose-rate but a lower dose-
rate is not clinically practical with the need for high patient throughput to help 
keep patient waiting lists under control.  
 
All IMRT dose distributions were planned and optimised on Oncentra Masterplan 
(OMP, Nucletron). These clinical plans were exported in DICOM format and then 
re-imported onto a water phantom set up in OMP. The dose distributions were 
calculated at the depth of dose maximum (dmax), this layer being set at the position 
of the scintillating screen. Calculation grid resolution was set to 0.1 × 0.1 × 0.1 cm3. 
 
The process requires conversion of dose in water to EPID image intensity, the 
methodology followed being similar to that of the GLAaS algorithm (General 
Linear "calibration" Algorithm for the Varian a-Si PortalVision aS500) presented 
by Nicolini et al. (2006). Every IMRT segment is considered as having two 
components; the primary beam and the portion transmitted through the MLC. MC 
simulations were used to compare dose in water (at dmax) with EPID image 
intensity both within the field (for a 10 × 10 cm2 field) and beneath the MLC, 
enabling dose conversion factors to be obtained.  
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It can be seen from figure 6.1 that there is a significant difference between water 
and EPID field size dependent output factors and so a single conversion factor 
converting from dose in water to EPID image intensity is not sufficient. Therefore, 
the equivalent window width field (EWWF), as defined by the MLCs, is calculated 
for every IMRT segment and a field-size dependant output factor, based on 
measurement, was applied to account for the difference between water and EPID 
field-size output factors. The EWWF is a similar concept to the ‘equivalent square’ 
commonly used in radiotherapy dose calculations for rectangular fields. 
Equivalent square = 2xy/(x+y)  (6.1) 
where x is the field width and y the length. In the EWWF, x is defined as the mean 
leaf aperture for all MLC leaves.  
 
The standard Varian EPID calibration procedure, which involves dividing every 
image by a ‘flood’ image was employed, resulting in flat images (as described in 
Chapter 4).  Therefore all OMP dose distributions were similarly divided by an 
OMP calculated ‘flood’ field of the same dimensions as the EPID flood field. 
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Figure 6.1. EPID and water field size output factors (FSFs), normalised to a (10 × 10) cm2 
field. 
 
 
Acquired images are compared with image predictions, gamma analysis being 
carried out for a 20% dose threshold. If greater than 10% of points fail gamma 
criteria of 3% maximum dose, 3 mm DTA further investigations are carried out. 
The process map of the technique is given in figure 6.2. 
 
Figure 6.2. Process map for INTREPID pre-treatment portal dosimetry. 
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6.2.1 Correction for Non-Uniform Backscatter 
As discussed in previous chapters, one of the biggest challenges facing those 
implementing portal dosimetry on Varian linacs is the non-uniform backscatter 
from components in the inline direction. When using the standard flood field 
calibration, the consequences are worst for small, off-axis fields, for which the 
scatter conditions deviate most from the flood field calibration conditions 
(Chapter 4, Cufflin et al. 2010a). Additionally, off-axis response in EPID differs 
from that in water due to different detection sensitivities to varying beam 
qualities off-axis, a consequence of the cone-shaped, high density, flattening filter 
within the linac (Parent et al. 2006). The method described here to correct for 
non-uniform backscatter also incorporates correction for any discrepancies in the 
results due to the differing response to the off-axis beam softening.  
 
The first step was to investigate the magnitude of the non-uniform backscatter 
effect and how it varied with detector position. The imager was irradiated with a 
sequence of small square fields with matched edges covering as much of the 
detector area as possible without irradiation of the read-out electronics. To this 
end, (3 x 3) cm2, (4 x 4) cm2, (5 x 5) cm2, (6 x 6) cm2, (8 x 8) cm2, (10 x 10) cm2 and 
(15 x 15) cm2 fields were explored. Corresponding fields were set up on the TPS, 
divided by the TPS ‘flood field’, and the ratio of the central point of each EPID 
measured field to TPS field was calculated. These results were used to form a 
series of matrices, which were interpolated and smoothed within Matlab enabling 
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a field size and position dependent correction to be applied to every IMRT 
segment. Using the TPS calculated doses for this correction was justified as the 
TPS has previously been extensively commissioned for off-axis fields, very good 
agreement between TPS and measurement being obtained within the central ± 10 
cm in both directions. It is very unlikely that an IMRT field would extend 
significantly beyond this range. Alternatively, measurement or MC simulation 
could be used instead of TPS calculated doses for these off-axis fields, but still 
applying the principles of this method.  
 
Initially, as a part of this work the ‘gravitational centre’ of every IMRT segment 
was located and the non-uniform backscatter correction applied to each segment 
was based on this position only. However, IMRT segments are far more complex 
than simple square fields. For example, for segment 2 in figure 6.3, a gravitational 
centre of x = -4.6 cm,  y = -2.6 cm and an EWWF of 6.2 cm were calculated. This 
would result in a correction factor of 1.008 being applied to the segment, which is 
not representative of the correction required for the lower part of the segment (in 
the target direction). Appling a matrix of correction factors for this segment 
results in a factor of 1.005 being applied to the upper half of the segment, but a 
correction as great as 1.025 is applied to the lowest part of the segment, which is a 
much closer representation of the differential backscatter in reality. The best 
solution for complex segments, however, is to explicitly model the backscattering 
materials using MC methods as described in Chapter 4. 
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A detailed description of the processes contained within the automated Matlab 
script is given in figure 6.4.  
 
Figure 6.3. 4 segments of an IMRT beam demonstrating the complexity of segment 
shapes . This corresponds to beam 5 of patient 6 in table 6.1. 
 
 
6.3 Results 
For the first 10 IMRT treatment plans evaluated (a total of 82 beams from head 
and neck or pelvic plans), an average of 96% of points within the treatment field 
passed gamma criteria of 3% maximum dose, 3 mm DTA without the correction 
for backscatter included. Although in general these results are satisfactory, it can 
be seen from table 6.1 that a handful of beams produced poor results, with fewer 
than 90% of points passing gamma criteria of 3%, 3 mm. These beams all have at 
least one small segment off-axis in the inline direction. However, for fields with 
larger or more symmetric segments, satisfactory results are obtained without the 
correction for backscatter included.  
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Figure 6.4 Description of automated Matlab script processes. 
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Correction matrices are 
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The TPS DICOM dose file for each beam is 
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Patient 1 2 3 4 5 6 7 8 9 10 Overall 
Beam            
1 98.90 97.88 99.20 99.20 94.20 91.60 97.50 98.00 90.80 98.00  
2 98.60 97.98 98.80 98.10 96.40 98.40 98.70 97.90 98.00 98.20  
3 98.30 97.78 97.90 97.50 97.40 94.50 97.40 96.80 95.50 98.10  
4 99.00 98.55 98.70 98.40 98.10 94.30 98.10 99.00 96.80 86.60  
5 97.80 97.60 96.40 98.40 97.80 86.00 98.10 98.90 97.40 98.30  
6 99.50 97.33  93.30 99.20 88.40 98.20 94.50  98.30  
7 97.10 91.07  92.60 83.50 98.30 96.60 97.90  98.50  
8     98.10 92.00  90.60  93.40  
9     96.70 98.60  98.60  96.70  
10     94.90 95.70  90.80    
11     97.10 98.40      
12      98.80      
13      99.10      
14      89.40      
            
Average 98.46 96.88 98.20 96.79 95.76 94.54 97.80 96.30 95.70 96.23 96.40 
σ 0.81 2.59 1.11 2.68 4.32 4.41 0.69 3.22 2.89 3.96 3.34 
 
Table 6.1. Gamma pass results for 3%, 3 mm without correcting for differential 
backscatter. σ denotes the standard deviation. 
 
 
Figure 6.5 shows the gamma map and the local dose percentage difference for 
beams 5 and 6 of patient 6, without the correction for non-uniform backscatter 
included. It can be seen that both of the beams have small off-axis segments, which 
coincided with a poor gamma pass rate.  
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Figure 6.5. Results without non-uniform backscatter correction for A) Patient 6, beam 5 
and B) Patient 6, beam 6. The TPS digitally reconstructed radiographs (DRRs) at the 
imager source to axis distance (SAD) are also shown. NB The area outside the beam has 
been excluded from all calculations and therefore should not be interpreted according to 
the colour scale. 
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6.3.1. Results: Correction for Non
Figure 6.6 shows the correction matrices obtained for (3 × 3) cm
(6 × 6) cm2 fields. As expected, the correction increased with decreasing field size 
and distance from the central axis in the target direction. A maximum correction 
of 1.07 was applied at the corners of the imager in the target direction for th
3) cm2 fields, which decreased to 1.025 for (6 × 6) cm
no correction was required for fields of (10 × 10) cm
 
Figure 6.6. The correction 
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was a marked improvement for all beams for which more than 10% of points 
initially failed the gamma criteria (for beams with small off axis segments).  100% 
of beams had a pass rate of greater than 90% with the correction for backscatter 
included, with 6% failing these criteria without the correction for backscatter 
included. 
Patient 1 2 3 4 5 6 7 8 9 10 Overall 
Beam            
1 99.20 99.05 99.40 99.50 98.10 98.90 96.20 98.60 91.20 99.70  
2 98.40 98.38 98.50 98.10 98.50 98.80 98.60 97.80 97.90 98.60  
3 98.10 98.20 97.50 98.60 98.60 97.80 97.60 97.80 95.40 98.00  
4 99.10 98.80 99.20 98.30 98.60 97.60 97.90 99.00 96.40 93.20  
5 97.80 97.63 95.90 98.40 98.40 97.00 98.00 99.40 97.30 98.10  
6 99.50 98.57  97.00 99.20 96.80 98.70 98.60  98.20  
7 97.10 96.10  92.90 98.30 99.20 96.90 98.00  99.10  
8     98.80 97.10  98.80  97.10  
9     93.10 98.80  98.60  96.10  
10     97.40 95.70  99.10    
11     98.70 98.60      
12      99.40      
13      99.20      
14      99.50      
            
Average 98.33 98.10 98.10 97.54 97.97 98.17 97.70 98.57 95.64 97.57 97.89 
σ 0.87 0.99 1.44 2.18 1.68 1.17 0.90 0.55 2.66 1.95 1.55 
 
Table 6.2. Gamma pass results for 3%, 3 mm with the devised correction for backscatter 
included. σ denotes the standard deviation. 
 
Figure 6.7 shows the gamma map and the local dose percentage difference for 
beams 5 and 6 of patient 6, with the correction for non-uniform backscatter 
included. It should also be noted that at the delivered dose-rate of 300 MU min-1  
there are also IMRT dose delivery errors of approximately 0.3 MU present for 
significant areas of these beams due to dose contributions from the first segment 
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but not the final segment, which corresponds to 1 to 2% local dose difference for 
the areas of interest. Segments 1 to 4 of beam 5 are previously given in figure 6.3.  
 
6. 4 Discussion  
Correction for non-uniform backscatter from the imager arm and ancillary 
components downstream of the imager is a current problem for those wishing to 
perform dosimetric verification on Varian linacs (as detailed in previous chapter).  
One of the most recent papers on this topic, Berry et al. (2010) uses similar 
methods as those described here to address the problems associated with field-
size and position on the imager. They have described two methods of correction, 
the first involving acquired correction matrices, and the second involving a field-
size specific correction algorithm derived from the correction matrices. However, 
their correction matrices were sampled from a limited number of symmetric field 
sizes from (2 × 2) cm2 to (30 × 40) cm2 positioned on the central axis and so the 
method presented here is a more detailed evaluation of image intensity with field-
size and position. Additionally, they applied the nearest correction matrix large 
enough to cover the entire irradiated field, and so, for example, for a Y2 jaw 
position of 8.8 cm, the matrix for an (18 × 18) cm2 field is applied. Their algorithm 
for the smaller fields was based on extrapolation and not measurement of small, 
off-axis fields.   
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Figure 6.5. Results with non-uniform backscatter correction included for A) Patient 6, 
beam 5 and B) Patient 6, beam 6. The TPS digitally reconstructed radiographs (DRRs) at 
the imager source to axis distance (SAD) are also shown. NB The area outside the beam 
has been excluded from all calculations and therefore should not be interpreted according 
to the colour scale. 
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In contrast, the method described in this chapter applies a correction matrix for 
every IMRT segment based on off-axis measurement and EWWF defined by the 
MLC. This solution is novel and versatile, the methodology lending itself to all 
other EPID dosimetry methods, regardless of dose calculation algorithms used. As 
previously mentioned, measurement or MC simulation could be used as an 
alternative to TPS calculated doses for these off-axis fields.  
 
6.5 Conclusions 
The results to date show this technique to be an efficient method of IMRT pre-
treatment dose verification. The results were partly presented (in the form of a 
poster presentation) at the UK Radiation and Oncology Conference (UKRO) 2009 
(Cufflin et al. 2009a). The process is time efficient, requiring 10 minutes per 
patient on the linac and taking only a few minutes to calculate on the TPS. The 
devised correction for non-uniform backscatter improved agreement between 
predicted and measured EPID intensities, average gamma pass results are 
improved from 96% (σ = 3.3) to 98% (σ = 1.6), with a significant improvement of 
results for any fields with small segments off-axis in the target direction.  At least 
90% of all beams passed the gamma criteria of 3%, 3 mm.  
CHAPTER 7. APPLICATION OF INTEGRATED TREATMENT PLANNING AND EPID 
DOSIMETRY (INTREPID) METHOD FOR EXIT DOSIMETRY 
    
 
110 
 
 
 
Chapter 7 
Application of INtegrated TReatment 
Planning and EPID Dosimetry (INTREPID) 
Method for Exit Dosimetry 
 
7.1 Introduction 
Progressing the description in previous chapters of pre-treatment EPID dosimetry 
techniques, two methods of transit EPID dosimetry (that verify the correct dose 
delivery during treatment) have also been developed as a part of this work. The 
first, the focus of this chapter, calculates the IMRT dose at the exit plane within the 
TPS. A series of pre-calculated correction factors, dependent on patient thickness, 
field size and position, are used to convert the dose (to a water equivalent 
medium) at the detector level to EPID image intensity, for comparison against 
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patient acquired EPID images. The second method, as described in detail in the 
following chapter, involves a full forward MC calculation of portal dose. 
 
As treatment plans and processes become more complex, the risk of potential 
errors increases, but they become more difficult to detect. The ultimate aim of 
radiotherapy dose verification is to ensure that all potential errors, whether they 
arise from the TPS dose calculation, incorrect patient positioning, changes in 
patient anatomy, data transfer malfunctions or linac functioning or calibration 
issues, are identified. The overall aim is to ensure that all patients get their 
treatment as planned. EPID dosimetry techniques, alongside image guided 
radiotherapy (IGRT) methods such as 3D cone beam CT, should enable the 
majority of errors undetected by other methods to be identified and corrected for.  
 
Errors arising from the TPS may be due to incorrect modelling of MLC 
transmission, inability to model inter-leaf leakage, incorrect Hounsfield Unit (HU) 
to electron density (ED) conversion of CT data or a weakness in the calculation 
algorithm used. For IMRT treatments it is imperative that the TPS models leaf 
transmission correctly. The collimators (jaws) remain static for each IMRT beam 
on our Varian 2100 linacs, and so errors in TPS leaf transmission become 
significant for beams comprising many segments.  Incorrect HU to ED conversion 
becomes more pronounced for larger patient thicknesses due to a greater absolute 
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error in calculated radiological depth, or effective depth relative to water. MC 
simulations carried out as a part of this work have shown that at 6 MV a 2% error 
in calculated radiological depth at 10 cm deep would result in a dose error of less 
than 1%, but the error in calculated dose would be almost 3% at 35 cm deep. 
Therefore HU to ED conversion errors become significant when performing exit 
dose calculations for large patients.  
 
Changes in patient anatomy between planning CT and treatment, or throughout 
the course of treatment, may be due to weight loss or gain, the emptying or filling 
of a body cavity, or tumour shrinkage as a response to treatment. Care should be 
taken within every radiotherapy department to set up adequate protocols for 
scanning and treatment to ensure that patient positioning and anatomy are as 
reproducible as possible throughout the course of treatment. 
 
All centres delivering radiotherapy are required to have a thorough system of 
routine machine quality control (QC) in place to ensure any changes in machine 
functioning or calibration are detected (Mayles et al. 1999). Additionally, all 
centres delivering complex treatments, such as IMRT, should have a thorough 
system of MLC QC in place to ensure the leaves are being driven to the correct 
position. However, even the most rigorous systems of routine QC cannot 
completely prevent a machine occasionally malfunctioning during treatment. EPID 
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dosimetry techniques should enable the magnitude and consequence of any 
machine faults to be assessed, as well identifying any accidental changes to plan 
parameters, whether they be due human or computer errors (Mans et al. 2010). 
 
As already stated in the introduction (chapter 1), published transmission 
dosimetry techniques include (i) point dose verification by back-projection 
methods to a set location (usually 5 cm deep or the isocentre) within the patient, 
(ii) 2D transit dose verification at EPID level, (iii) 2D dose verification at the 
patient level (either exit dose or mid-plane) and (iv) 3D dose calculation within 
the patient, either by a back-projection dose calculation algorithm or back-
projection of energy fluence and forward calculation of dose within the patient. 
 
Van Elmpt et al. (2008a) point out the vast range of publications in the literature 
yet current lack of commercially available transmission (or transit) dosimetry 
solutions. ‘Dosimetry Check’ from Math Solutions (see chapter 1, section 1.5), 
based on the methods presented by Renner et al. 2005, claims to be the first 
commercial EPID based transit dosimetry solution. A preliminary study at 
Edinburgh Cancer Centre, with a poster presentation at the IPEM Biennial 
Radiotherapy meeting (Sankar et al. 2010), showed agreement between EPID 
measurements and TPS dose of 3.67 ± 0.8% at the isocentre for phantom studies. 
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The first clinical case showed agreement between EPID image and TPS of 5.8% at 
isocentre.  
 
The method developed as a part of this work involves 2D transit verification at the 
EPID level by calculation of dose to a water equivalent ‘EPID’ within the TPS, using 
the CC algorithm available within our TPS. Conversion to EPID image intensity is 
achieved through application of a series of pre-calculated correction factors 
dependent on patient thickness and segment size, shape and location on the 
imager. Several other groups have used the TPS and / or convolution 
superposition algorithms to calculate the dose at the EPID level (McNutt et al. 
1996, Dahlgren et al. 2002, 2006, Mohammadi et al. 2006, Reich et al. 2006). 
However, these publications relate to older EPID models, e.g. the Scanning Liquid 
Ion Chamber (SLIC) EPID (van Herk and Meertens 1988) and charged coupled 
device (CCD) EPIDs. The SLIC EPID was essentially water equivalent and, as water 
is the reference medium for radiotherapy dosimetry, the conversion to EPID 
intensity was much simpler than for the higher effective atomic number and 
density of the a-Si EPID. In addition, these papers refer to phantom studies only. 
The author is unaware of clinical studies using these techniques being published 
at this time. 
 
The UK report ‘Towards Safer Radiotherapy’ has expressed support for the 
development of EPID-based approaches to patient dose verification. In line with 
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this, the aim of this work is to set up an accurate and efficient method of verifying 
our clinical IMRT plans at treatment time using the Varian aS500 EPID. The 
technique is readily transferrable to the EPIDs provided by other linac vendors. 
 
7.2 Methods 
All dose distributions are planned and optimised on OMP. OMP has versatile 
DICOM export and import functions, enabling the patient CT dataset and 
treatment parameters to be exported and then imported into Matlab software 
(developed for this project), where it can be rotated around the plan isocentre by 
the relevant gantry angle and the water equivalent ‘EPID’ layer attached at the 
appropriate level and position. The modified CT data is then re-imported into OMP 
(see figure 7.1) to enable calculation of dose in water at the EPID level.  The 
process for rotation and addition of the EPID is similar to that described in 
Chapter 8 for creation of MC phantom files, but the final product is a modified CT 
dataset.  
 
The OMP calculated dose to water equivalent ‘EPID’ is exported and a series of 
correction factors applied within Matlab to convert to EPID image intensity. The 
four correction factors applied are (i) conversion from dose in water to EPID 
image intensity, (ii) a field-size dependent output factor to account for the 
difference between water and EPID field size factors, (iii) an off-axis correction 
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matrix to account for effects of off–axis beam ‘softening’ at different depths and 
(iv) correction for non-uniform backscatter from the Varian EPID support arm and 
cabling. A process map describing the procedure is given in figure 7.2. 
 
   
 
Figure 7.1. Rotated CT data set and attached ‘EPID’ within the TPS. 
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Figure 7.2. Process map for INTREPID transit dosimetry. 
 
 
 
7.2.1 Verification of Dose Calculation at the Exit Plane 
MC simulations were used to evaluate the ability of the TPS to calculate doses 
correctly at the exit plane for the variety of algorithms available on OMP; the 
standard or ‘classic’ PB and CC algorithms and the newer ‘enhanced’ CC algorithm, 
more detail on these algorithms being given in chapter 2. The CC ‘enhanced’ 
calculation is more suited to this work due to the modelling of MLC inter-leaf 
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leakage, faster calculation times and improved calculation matrix resolution over 
the CC ‘classic’ calculation. Water equivalent thicknesses of 5, 9, 15, 20, 25, 30 and 
35 cm were investigated. Figure 7.3 shows the set-up for calibration of the system. 
 
MC simulations of our Varian 2100 CD linacs with aS500 EPIDs were performed 
using the BEAMnrc and DOSXYZnrc codes, which make it relatively easy to 
replicate the exact set-up both on our Varian accelerators and within the TPS. It 
should also be noted that the work described in this chapter was carried out for 
comparison with full-forward MC calculation of portal dose using these codes (as 
described in the next chapter). The TPS based technique has the advantage that 
results can be obtained more quickly in a clinical setting and it includes the initial 
TPS dose calculation that the patient plan approval was based upon, and so 
combines verification of the TPS dose calculation with verification of treatment 
delivery.  
 
Figure 7.3. The calibration set up for MC, TPS calculation and measurement.  
 Water Equivalent ‘EPID’ 
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7.2.2 Hounsfield Unit to Electron Density Conversion 
Correct calculation of dose at the exit plane is also dependent on correct HU to ED8 
conversion, both at the CT scanner and within the TPS. Therefore the scanner and 
TPS HU to ED curves were compared against each other and against the formulae 
presented by Thomas 1999 (equations 7.1 and 7.2).  
HU = (ED-1) × 1000     (7.1) 
for tissues of densities less than that of bone, and  
HU = (ED-1) × 1950     (7.2) 
for bone densities.  
 
The HU to ED conversion for the scanner was determined by scanning the CIRS 
Model 062 phantom9 (figure 7.4) with a range of tissue equivalent ‘nested disks’ of 
known densities for the various clinical protocols used. The HU to ED conversion 
for OMP was obtained from the Oncentra® MasterPlan v3.3 Physics and 
Algorithms Manual. 
 
                                                            
8
 It should be noted that generally within radiotherapy, and within this thesis, ED 
refers to the electron density relative to that of water. 
9
 http://www.cirsinc.com/062_rad.html 
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Figure 7.4. CT scan of CIRS electron density phantom. 
 
 
7.2.3 Determination of Correction Factors 
7.2.3.1 Correction Factor 1: OMP Dose in Water to EPID Image 
Intensity 
For conversion of OMP dose in water to EPID image intensity, every IMRT 
segment is considered as comprising two components; the primary beam and the 
‘leakage’ portion transmitted through the MLC. MC simulations were used to 
compare dose in water with dose in EPID both within the field (for a standard (10 
× 10) cm2 aperture) and beneath the MLC, enabling dose conversion factors to be 
obtained. These factors were initially obtained for transmission through 
thicknesses of water equivalent material from 6 cm up to 35 cm (as this was the 
maximum thickness of ‘solid water’ material available locally at the time this work 
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was carried out), although this range needs to be extended for the full range of 
patient thicknesses that may be encountered.   
 
7.2.3.2 Correction Factor 2: Field Size Output Factors 
The variation of EPID and water field size output factors with increasing tissue 
thickness was investigated. The EWWF (defined in Chapter 6) was calculated for 
every IMRT segment, enabling the field-size output factor (accounting for the 
difference between water and EPID field size factors) to be applied. 
 
7.2.3.3 Correction Factor 3: Off-Axis Calibration Matrices 
Additionally, the variation of EPID response compared with dose in water for ‘off-
axis’ positions due to beam spectral changes was investigated for water equivalent 
thicknesses of 6 cm to 35 cm.  
 
7.2.3.4 Correction Factor 4: Correction for Non-Uniform 
Backscatter 
As detailed in previous chapters, correction for non-uniform backscatter from the 
Varian support arm and cabling was required. The matrix-based method 
described in Chapter 6 was adapted to account for different tissue thicknesses. 
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These correction matrices, dependent on tissue thickness, segment size and 
position on the imager, were acquired by irradiating the imager with a series of 
fields (from (3 × 3) cm2 to (12×12) cm2) with matching edges to cover the entire 
detector area, for thicknesses of water equivalent material from 6 cm to 35 cm. 
Equivalent fields were calculated on the TPS, enabling field size and tissue 
thickness dependent correction matrices to be produced. 
 
7.2.4 EPID Positional Stability with Gantry Angle 
Iori et al. 2010 reported the positional reproducibility of the support arm to be the 
biggest hurdle when using the Varian EPID for IMAT verification. However, this 
paper referred to the older ‘R’ arm, whereas the work in this thesis has been 
carried out with an EPID on the newer ‘Exact’ arm, which is known to have 
superior mechanical alignment with gantry angle over the ‘R’ arm. The ‘R’ arm will 
have to be considered when extending this work as two of our older EPIDs have 
this arm. The study by Grattan and McGarry [2010] reported that their largest 
measured misalignments from EPID stated values for the Exact arm were a lateral 
shift of −0.4 ± 0.3 mm and a longitudinal shift of +1.9 ± 0.9 mm, both at gantry 
angle 180°. These reported misalignments were within the specified manufacturer 
tolerance of 3 mm from EPID values. Although work is under way to investigate 
EPID position and reproducibility with gantry angle for the EPIDs at VCC Cancer 
Centre, for the purposes of this work predicted EPID images were shifted in 2D to 
obtain the best match with acquired EPID images. This method should also 
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maintain the correct back-scatter and off-axis correction.  Additionally, the vertical 
position of the imager also varies slightly with gantry angle and so the reported 
position was obtained from the DICOM information and image scaling and inverse 
square law corrections applied for any slight offsets.  
 
7.2.5 Clinical IMRT Treatment Verification 
The technique was initially validated for IMRT fields through water equivalent 
material at a gantry angle of 0°, before moving on to validate the technique for a 
Alderson Rando anthropomorphic phantom (figure 7.5), and then finally to verify 
actual patient IMRT treatments with variable gantry angles.   
 
A clinically prepared head and neck IMRT plan of 14 beams was used to verify the 
technique for thicknesses of water equivalent material of 15, 21, 25 and 35 cm. A 
single (10 × 10) cm2 field and 10 beams from a prostate plus pelvic nodal IMRT 
plan were used to verify the technique on the Rando phantom. To date, 68 clinical 
exit dosimetry beams have been evaluated, from a combination of 4 head and neck 
and 4 prostate plus pelvic nodal IMRT plans.  
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Figure 7.5. Transverse CT slice of the Rando anthropomorphic phantom with attached 
‘EPID’. 
 
 
7.3 Results 
7.3.1 Verification of Dose Calculation at the Exit Plane 
Figure 7.6 shows the dose calculation through different thicknesses of water 
equivalent material for the MC simulation and OMP CC ‘classic’, CC ‘enhanced’ and 
PB ‘classic’ algorithms. MC verified the ability of OMP CC algorithms to calculate 
the transmitted dose correctly at the EPID level, there being very good agreement 
between the CC ‘classic’ algorithm and MC simulation for all thicknesses 
investigated (a difference of less than < 0.5%). The CC ‘enhanced’ algorithm 
showed similarly good agreement for water equivalent thicknesses of 5, 9, 30 and 
 Water Equivalent ‘EPID’ 
CHAPTER 7. APPLICATION OF INTEGRATED TREATMENT PLANNING AND EPID 
DOSIMETRY (INTREPID) METHOD FOR EXIT DOSIMETRY 
    
 
125 
 
35 cm, but a 1.5% difference between CC ‘enhanced’ and ‘classic’ was observed for 
thicknesses of 15, 20 and 25 cm. This is being investigated further and may be due 
to the local implementation of the algorithm. This work also proved the 
unsuitability of the PB algorithm for this work, with a difference of up to 15% 
between PB calculation and MC simulation for a thickness of 35 cm of water 
equivalent material. Due to calculation matrix resolution issues when using the CC 
‘classic’ algorithm for these very large extended phantom geometries, a decision 
was made to use the CC ‘enhanced’ algorithm for the remainder of this work. 
 
 
Figure 7.6. Dose calculation through different thicknesses of water equivalent material 
for MC simulation and Oncentra Masterplan CC ‘classic’, CC ‘enhanced’ and PB ‘classic’ 
algorithms. It should be noted that due to the excellent agreement between MC and CC 
‘Classic’, many of the MC data points are hidden behind the CC ‘Classic’ data points. 
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Figure 7.7. Relative electron density versus HU for the VCC scanner, Oncentra Masterplan 
(OMP) and calculated using Thomas 1999. From figure 7.7a it can be seen that in general 
there is good agreement between all three curves, although there is a discrepancy 
between the OMP and scanner HU to ED conversion around HU of -96 (figure 7.7b), which 
corresponds to adipose / fat tissue.   
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7.3.2 Hounsfield Unit to Electron Density Conversion 
The graphs in figure 7.7 show the three calibration curves for the CT scanner (the 
scanner’s prostate protocol is shown, although this is very similar to all other 
clinical protocols used), OMP and for the method for converting ED to HU 
described by Thomas 1999. It can be seen that there is generally good agreement 
for all three curves, except in the region around HU of -96. OMP assigns an ED of 
0.95 for HU equal to -96, but the formula presented by Thomas 1999 gives an ED 
equal to 0.904 for this HU, a difference in ED of 5%. The CT scanner curve more 
closely matches that presented by Thomas 1999, an ED of approximately 0.91 
corresponding to HU of -96.  
 
The graph in figure 7.7b suggests that OMP over-estimates the ED for materials of 
HU in the region -200 to -50, which mainly corresponds to patient adipose or fat 
tissues. However, this is only likely to become an issue with patients with a large 
amount of adipose or fat tissue in the beam path. For example, for a large prostate 
patient with 10 cm adipose tissue in the beam path, a mis-calculation of 
radiological depth by 0.5 cm would result in approximately 2% error in the dose 
calculation. Dose errors are therefore likely to be less than 1% at isocentre for 
most patient cases. 
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7.3.3 Determination of Correction Factors 
7.3.3.1 Correction Factor 1: OMP Dose in Water to EPID Image 
Intensity 
As expected, both dose in water and EPID image intensity followed an 
approximate exponential with increasing patient thickness (figure 7.8). The ratio 
of the two curves was found to vary with depth and so a tissue thickness 
dependent conversion factor was required.  
 
For transit verification based on patient CT, the TPS calculated radiological depth 
at the central axis was used for this position. The radiological depth at all other 
calculation points was approximated by calculating the dose for a large beam at 
the exit plane within the TPS and comparing the dose at all points against the 
central axis dose. An approximation that mean attenuation in tissue is 4% per cm 
is currently used, based on the MC simulation results. Relative dose under the 
MLCs was found to be 25 – 35% greater in EPID than for water equivalent 
material. A value of 30% was used in this work. 
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Figure 7.8. EPID intensity and MC exit dose in water for varying thickness of water 
equivalent material. 
 
 
7.3.3.2 Correction Factor 2: Field Size Output Factors 
The average ratio of EPID field size output factor to water field size output factor 
for thicknesses of water equivalent material of 6 cm to 35 cm are shown in figure 
7.9. The factors were not found to vary significantly with depth, and so a standard 
correction factor for a given field was applied for all depths (the maximum 
standard deviation being 1.1% for an equivalent square of 15 cm). 
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Figure 7.9. Average ratio of EPID field size output factor to water field size output factor, 
for thicknesses of water equivalent material of 6 cm to 35 cm. 
 
 
 
 
7.3.3.3  Correction Factor 3: Off-Axis Correction Matrices 
 
Figure 7.10 illustrates the ratio of EPID image intensity to dose in water for a large 
beam exiting different thicknesses of water equivalent material The results of 
these measurements proved it necessary to apply different water to EPID off-axis 
correction matrices for all tissue thicknesses to account for the differing EPID 
response to spectral variations in the beam with distance away from central axis 
and with depth. 
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Figure 7.10. Off-axis correction. Ratio of EPID image intensity to dose in water for beam 
exiting A) 10 cm, B) 20 cm and C) 30 cm thickness of water equivalent material.  The grid 
visible is due to the attenuation of the ‘tennis racquet’ couch top.  
 
 
7.3.3.4 Correction Factor 4: Correction for Non-Uniform 
Backscatter 
Figure 7.11 shows example correction matrices for non-uniform backscatter with 
(5 × 5) cm2 fields for thicknesses of 10 cm and 20 cm water equivalent material. It 
can be seen that different correction matrices are required for different tissue 
thicknesses, correction values increasing with increasing patient thickness. As in 
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figure 6.6 in the previous chapter, a greater correction is required for the inferior 
portion of the EPID due to non-uniform backscatter from supporting structures. 
 
 
Figure 7.11. Matrices for correction for non-uniform backscatter through a) 10 cm water 
equivalent material and b) 20 cm water equivalent material for (5 × 5) cm2 fields. 
 
 
 
7.3.4 EPID Positional Stability with Gantry Angle 
Initial measurements found the maximum displacement of the centre of the 
imager panel from the stated position to be 0.4 mm laterally and 1.6 mm 
longitudinally, both for gantry angle 180°. However, the reproducibility of position 
with gantry angle for our EPIDs is yet to be determined and so, as already stated, a 
2D shift to best align predicted images with acquired images is currently 
performed.  
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7.3.5 IMRT Plan Verification 
Results for transit IMRT verification through homogeneous water equivalent 
material were very good, an average of 96% and 98% of points passing gamma 
criteria (gamma < 1) of 3%, 3 mm and 4%, 4 mm respectively, for thicknesses of 
water equivalent material of 15, 21, 25 and 35 cm.  However, for a (10 × 10) cm2 
beam incident on the Rando phantom there was a discrepancy of approximately 
4.5% on the central axis. Further investigation revealed the ratio of measured 
radiological depth to physical depth for Rando to be much lower than that for 
standard patients, the ratio being approximately 0.9. From figure 7.7b it can be 
seen that Rando’s relative electron density corresponds to the region with the 
greatest disparity between the scanner and OMP HU to ED conversion curves. It is 
believed that adjustable HU to ED curves will be available in a new release of OMP, 
but this is not available at present. As this is an extreme situation (Rando consists 
of more than 20 cm of fat / adipose equivalent tissue), in order to correct for this 
the Rando CT data set was adjusted within Matlab to enable the correct ED to be 
applied within OMP (to ensure correct calculation of radiological depth). This 
greatly improved agreement between prediction and measurement, there being 
less than a 1% difference for a (10 × 10) cm2 exit dosimetry field. With the 
‘corrected’ CT data, an average of 95% of points passed gamma criteria of 4%, 4 
mm and an average of 98% of points passed gamma criteria of 5%, 5 mm for 10 
fields from a prostate patient IMRT plan. 
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Figure 7.12. Acquired EPID Image and Calibrated TPS Image for a prostate beam. NB The 
area outside the beam has been excluded from all calculations and therefore should not 
be interpreted according to the colour scale. 
 
 
Patient 
Number 
Region Number 
of beams 
Average percentage of 
points passing gamma 
5%, 5 mm 
Standard 
deviation 
(%) 
1 Head and 
neck 
14 97.6 2.2 
2 8 96.1 2.9 
3 10 96.4 2.7 
4 5 96.0 3.3 
5 Prostate plus 
nodes 
8 98.5 1.0 
6 10 91.4 8.5 
7 7 95.3 3.8 
8 6 96.9 3.4 
Overall 
Average 
 68 96.0 3.5 
Table 7.1. Average percentage of points passing gamma criteria of 5%, 5 mm (gamma < 
1) for 8 patients evaluated. Anterior and anterior oblique beams exiting couch bars have 
been removed. 
 
To date a total of 68 beams from 4 head and neck and 4 pelvic plans have been 
evaluated, with an average of 96% of points passing gamma criteria of 5%, 5 mm 
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(when all anterior and anterior oblique beams that exit couch bars are removed as 
these are not accounted for within the TPS). Table 7.1 summarises all results 
obtained and figure 7.11 gives the visual result obtained for a clinical prostate 
plan. 
 
It can be seen from table 7.1 that the results for patient 6 were noticeably poorer 
than the results for the other 7 patients evaluated. Detailed results for this patient, 
and a comparison with MC simulation are given in table 7.2. The availability of the 
full-forward MC technique allows for a direct comparison using the same pre-
treatment CT set to aid in identifying the cause of any discrepancies. It can be seen 
that there is very good agreement between TPS technique and MC simulation for 
all beams, both techniques showing poor verification results for beams 2, 5, 6 and 
9. Further analysis of this patient’s scan revealed the patient to have a very full 
bowel during initial planning scan, and all 4 beams with poor verification results 
corresponded to beams with a lot of bowel in the beam’s eye view. It is therefore 
unlikely that the patient retained this full bowel throughout treatment. Figure 7.13 
shows the CT scan, beam’s eye view and gamma maps for beams 5 and 6. 
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Beam Number TPS Based 
Technique versus 
acquired EPID 
Image 
5%, 5 mm 
MC Simulation 
versus acquired 
EPID image 
5%, 5 mm* 
TPS Based 
Technique versus 
MC Simulation 
5%, 5 mm* 
1 99% 98% 99% 
2 76% 77% 100% 
3 97% 99% 100% 
4 98% 95% 100% 
5 78% 71% 100% 
6 90% 91% 99% 
7 96% 95% 100% 
8 95% 99% 99% 
9 87% 77% 99% 
10 99% 98% 100% 
    
Mean 91% 90% 99% 
Table 7.2. Detailed gamma pass results for patient 6. 4 beams (italicised) demonstrate 
poor verification results. It should be noted that for beams such as beam 5 with very good 
agreement between TPS and MC simulation, a larger difference in TPS versus EPID is due 
to the abrupt cut off of 5%, 5 mm. 
* uncertainty on MC simulation 1 -2% 
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Figure 7.13. Verification results for beams 5 and 6 in table 7.3. A) Location of beam 5 on 
CT scan (green), B) Beam 5 Beam’s Eye View, C) Beam 5 gamma map, D) Location of beam 
6 on CT scan (green), E) Beam 6 Beam’s Eye View, F) Beam 6 gamma map. NB The area 
outside the beam has been excluded from all calculations and therefore should not be 
interpreted according to the colour scale. 
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Initial evaluation of patient 4 in table 7.1 additionally showed a poor verification 
result, with an average of only 83% of points (standard deviation 5.7%) passing 
gamma criteria of 5%, 5 mm. It was known that this patient had positional 
problems for the first fraction, so a request to repeat images was made. On 
acquiring images on the subsequent fraction, the average verification pass-rate of 
96% shown in table 7.1 was obtained, and the technique verified the patient’s 
shoulder to be in the incorrect position for the first fraction, which would not be 
picked up by the standard isocentre set-up images of (12 × 12) cm2. Figure 7.14 
below shows the coronal view, beam’s eye view and gamma passes for fractions 1 
and 2 for beam 3 for this patient plan. 
 
 
 
 
 
 
 
 
 
 
Figure 7.14. Gamma maps for subsequent fractions for a patient with known positional 
problems. A) Coronal view B) Beam’s Eye View (green) C) Gamma map fraction 1 D) 
Gamma map fraction 2. NB The area outside the beam has been excluded from all 
calculations and therefore should not be interpreted according to the colour scale. 
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Figure 7.15. Example gamma pass for an anterior beam exiting a couch bar. NB The area 
outside the beam has been excluded from the calculation and therefore should not be 
interpreted according to the colour scale. 
 
 
The technique described here has proved to be a very useful tool in the 
verification of IMRT delivery during treatment. However, there are still currently 
some limitations with its use. The main limitation is the size of the imager. The 
Varian aS500 EPID is only 30 cm × 40 cm and all our IMRT beams are very large 
(prostate plus nodal IMRT or multiple PTV head and neck IMRT). With the imager 
positioned at 140 cm SDD, an average of 25% of our IMRT treatment beams do not 
fit on the panel. The pre-treatment method was not subject to the same limitations 
as it was possible to rotate the collimator until the beam fitted on the imager. 
Additionally, anterior or anterior oblique beams may exit the moveable couch bars 
(the bars are moved out of the beam for posterior or posterior oblique beams so 
as not to affect the dose delivered to the patient, but this is more difficult for 
anterior beams). Figure 7.15 gives an example gamma result for an anterior beam 
exiting a couch bar. However, there is a new couch available from Varian which 
removes this issue. In addition, due to the lack of treatment time CT scan facilities 
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on our current generation of Varian linacs, any true differences in patient anatomy 
between planning CT scan and treatment are unknown. This area will however be 
a productive one for future research and development work. 
 
7.4 Conclusions 
The Netherlands Cancer Institute (NKI) verify all their radiotherapy treatments 
(except for single fraction treatments or fields which are too large to fit on the 
imager) using their in-house back-projection EPID dosimetry technique. Mans et 
al. (2010) reports that they verified 4337 plans between January 2005 and August 
2009, identifying 17 serious incidents, 9 of which would not have been detected 
by pre-treatment verification. The paper focuses particularly on a rectum plan 
that was corrupted during data transfer, resulting in an average difference 
between plan and treatment of 11.6%, local dose differences being as great as 
20%. It is believed that the technique described in this thesis would also identify 
such errors. 
 
OMP is a planning system with continual new developments. It is believed that the 
package will include a fast MC calculation algorithm for photons within the next 
12 months. This development should enable this technique to be adapted to 
enable the high density materials to be incorporated into the EPID model and so 
conversion to dose in water and application of the multiple correction factors 
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would not be required. Additionally, modelling of the support arm and cabling 
would enable a simpler solution for the non-uniform backscatter effect.  
 
Although still in the development phase, the results of INTREPID applied to exit 
dosimetry are very promising. This technique was presented at EPI2kX, the 
international Electronic Portal Imaging Conference in Leuven, Belgium (Cufflin et 
al. 2010b) and at the IPEM Biennial Radiotherapy Meeting (Cufflin et al. 2010c). 
The results obtained showed very good agreement with full forward MC 
calculations for the IMRT cases cited above. This technique, which could easily be 
transferred to EPIDs from all vendors, enables verification results to be analysed 
quickly in a clinical setting and has the advantage that it uses the same TPS that 
was used for initial optimisation and dose calculation of the patient IMRT plan. To 
date a total of 68 beams from 4 head and neck and 4 pelvic plans have been 
evaluated, with an average of 96% of points passing gamma criteria of 5%, 5 mm. 
Additionally, the technique has also proven its ability to pick up dose errors due to 
changes in patient position or patient anatomy.  
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Chapter 8 
Monte Carlo Patient Dose Verification 
 
8.1 Introduction 
One of the aims of this work was to develop a method for full forward MC 
calculation of portal dose at the imager plane for comparison against acquired 
EPID images of patients. This involves simulating the radiation transport, beam by 
beam, throughout the complete patient and EPID geometry within DOSXYZnrc. In 
the process the MC calculated dose within the patient is obtained ‘for free’. With 
simple rotation and addition of the 3D dose files generated by DOSXYZnrc, the MC 
calculated dose within the patient can also be compared directly with that 
calculated by the TPS, providing an additional check of the TPS dose calculation 
for the patient plan. Uncertainties of 2% at the imager plane result in uncertainties 
of approximately 0.5% within the patient (per beam), and so a very accurate 
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calculation of dose within the patient may be obtained provided other parameters 
such as the HU to electron density conversion and cross section data are 
sufficiently accurate.  
 
It is a requirement that an independent monitor unit calculation is performed for 
all clinical radiotherapy plans (Royal College of Radiologists 2008). The more 
complex the treatment technique the more complex these check calculations 
become, calculation methods becoming particularly complicated for sophisticated 
planning and delivery techniques such as IMRT. A number of MU check calculation 
programmes are available, but these are very limited as they are only able to 
provide confirmation of dose at a point, and account for patient inhomogeneties 
using the radiological depth method, which is only valid if lateral charged particle 
equilibrium is maintained. For this reason many centres still verify the delivery of 
every patient’s IMRT treatment plan on a phantom. However, although this 
method confirms the correct delivery of the patient plan, phantoms used for 
routine verification are usually constructed of uniform perspex or water 
equivalent material, and so this procedure only confirms the ability of the TPS to 
calculate the dose correctly to a uniform phantom and not necessarily to the 
heterogeneous patient anatomy. 
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The method proposed in this chapter for full forward calculation of portal dose 
enables confirmation of the dose delivery during treatment, combined inherently 
with an accurate, 3D dose comparison of the TPS plan calculation for the patient.  
 
8.2 Methods 
8.2.1 Full Forward Calculation of Portal Dose 
The process map for this technique is given in figure 8.1. As a pilot study, full 
forward MC calculation of portal dose was carried out for a total of 8 patient IMRT 
plans from a combination of prostate and head and neck treatments, all plans 
having been originally planned and optimised on OMP. The patient CT dataset and 
plan parameters were exported in DICOM format from OMP and imported into 
Matlab software. The plan parameter file includes all information to enable the CT 
data to be rotated about the patient plan isocentre by the relevant gantry angle so 
that the full 31 layer EPID model (including the non-uniform slabs of 
backscattering material to represent the support arm and cabling) can then 
attached at the relevant position perpendicular to the beam direction (figure 8.2).   
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Figure 8.1. Process map for MC Exit dosimetry. 
The method for rotating the patient CT dataset followed a similar routine to the 
‘TWIZ&GLU’ routine described by Chin et al. (2003), Chin (2005). Chin described a 
3 step routine to enable variable gantry angle simulations with the SLIC EPID, the 
routine involving 1) rotating the phantom by –‘gantry angle’ around the isocentre; 
2) “padding” the exterior of the phantom with additional air-filled voxels to obtain 
a rectangular frame; and 3) adding the EPID beneath the phantom at a specified 
SDD. The integrated phantom was then ready to serve as input for a DOSXYZnrc 
run, in which the beam was directed as if the gantry was not rotated. The routine 
performed as part of this work is very similar, the main differences being the 
replacement of the SLIC EPID with an aS500 EPID model, and a shift of the patient 
Patient CT dataset and 
IMRT plan parameters 
exported and 
imported into 
MATLAB software. 
CT dataset 
rotated about 
isocentre by 
relevant gantry 
angle.  
MC phantom (egsphant) 
files containing patient CT 
data and attached EPID 
created for every plan 
gantry angle. 
Simulations 
submitted to 
RTGRID 
service. 
MATLAB scripts utilise 
plan parameters to 
create BEAMnrc and 
DOSXYZnrc input 
scripts for each beam. 
MC EPID model 
(including additional 
backscatter material) 
attached at 
appropriate level and 
position.  
Resulting MC 3D dose files compared with acquired EPID images per beam. 
 
If required, 3D dose files can be rotated back by the relevant gantry angle 
and combined, enabling comparison of MC calculated dose within the 
patient to TPS calculated dose.  
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CT dataset so that the isocentre corresponds to the centre of the patient geometry 
in all planes prior to rotation. The isocentre being located at the centre of the 
geometry simplifies the task of adding the aS500 EPID model with additional 
backscattering material; the backscattering material is non-uniform and thus 
location relative to the isocentre is critical.  As stated by Chin (2005) this method 
ensures that the EPID model voxels correspond to the DOSXYZnrc orthogonal 
planes. Rotation of the continuous EPID contours would lead to inaccurate 
projection of the different thicknesses of the detector layers (figure 8.3).  
 
Figure 8.2. Showing a rotated patient CT slice with MC EPID model attached 
perpendicular to the beam direction for a beam gantry angle of 100°. 
 
 
The accelerator portion of the simulation was performed with BEAMnrc, radiation 
transport within the patient and EPID being simulated within DOSXYZnrc. Matlab 
scripts were written for automated creation of BEAMnrc and DOSXYZnrc input 
files for each IMRT beam using the plan parameters, this method requiring that 
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each beam be simulated separately.  The DOSXYZnrc coordinate system differs 
from the DICOM coordinate system used conventionally within radiotherapy (and 
within the TPS), and so conversion to the DOSXYZnrc coordinate system is 
required. However, as the technique described here involves a rotation of the CT 
image and all treatment plans investigated in this study consist of co-planar beams 
(treatment couch angle = 0°), the only variable was the beam collimator angle, 
which can easily be related to the parameter ‘phicol’ within DOSXYZnrc.  
 
Figure 8.3. Defining a patient / phantom dataset (P) and an imager (I) on a common 
rectilinear grid. Beam direction from the source (S) is shown: a) irradiation from gantry 
angle 0°; b) irradiation from oblique angle, where the voxel boundaries no longer 
correspond to imager surfaces. Reproduced from Chin 2005. 
 
In DOSXYZnrc, by default, each material in a CT phantom is indexed using a single 
digit ranging from one to nine, limiting the phantom composition to a maximum of 
9 materials, which is insufficient for the integrated phantoms developed in this 
work. Therefore, indexing was changed to use characters greatly extending the 
number of materials. DOSXYZnrc was similarly modified for compatibility. 
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The MC simulation requires conversion of the CT HU to electron densities 
according to the appropriate ‘ramp’ for the CT scanner used, the accuracy of this 
CT ramp playing a major part in the final accuracy of the MC simulation results. 
The CT ramp (figure 8.4) was obtained locally using the CIRS Model 062 phantom 
(figure 7.4), with multiple inserts of known electron density. Additionally, the 
DOSXYZnrc MC code requires correct material specification (according to ICRU 
1984), for example, soft tissue, bone, lung or air for all voxels. 
   
Figure 8.4 VCC scanner HU to electron density curve, the points representing the CIRS 
phantom inserts. 
 
 
All simulations were run with a resolution of (2 × 2) mm2, with 3 mm spacing 
between CT slices. Fine resolution is required for evaluation of complex IMRT 
plans with high dose gradients, although these simulations are computationally 
intensive for such large MC phantom (egsphant) files. Simulations were therefore 
run on the RTGrid service (chapter 2, Downes et al. 2009), which provides access 
to hundreds of PCs at Cardiff University via a web portal. Results for all beams for 
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a patient plan (up to 14 beams) are obtained within 24 hours. Although the 
method is time consuming it is possible to run the simulations prior to the patient 
starting treatment, enabling immediate evaluation of EPID images following the 
first fraction. To obtain uncertainties of around 2% at the EPID it was found 
experimentally that the number of histories required was given by equation 8.1.  
   
  	
   

  (8.1) 
where A is the beam area, nsplit is the photon splitting number, vvoxel the voxel size 
and s the required uncertainty. This ‘rule of thumb’ was developed from equation 
2.2. Photon splitting and DBS were set to 100 and 1000 respectively. 
 
As with all MC simulations of Varian linacs it was necessary to correct for 
backscatter from the jaws to the monitor chamber using the method described by 
Liu et al. (2000). It was found that the position of the MLCs had no effect on the 
backscatter to the monitor chamber and so a single factor was used per beam (the 
jaws currently remain at a fixed position for each IMRT beam). Calibration was 
performed for a single (10 × 10) cm2 field exiting a 15 cm thickness of water 
equivalent material, the MC simulation being calibrated directly against an EPID 
measurement with the same set-up. Some of our EPID panels are ageing and (from 
time to time) moved between different linacs, so it was deemed necessary to 
perform a calibration measurement each week on the particular machine on 
which patient exit images were to be taken. Additionally it was necessary to divide 
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all MC simulations by a MC ‘flood’ image, as per the standard Varian calibration 
procedure (equation 4.1). 
 
The exit dose images obtained were evaluated using the 2D gamma evaluation 
method for a 20% dose threshold using ‘pass’ criteria of 5%, 5 mm. Gamma 
criteria of 5%, 5 mm have been used for all exit dosimetry work in this thesis as 
changes in patient anatomy between planning CT and treatment make 3%, 3mm 
an unrealistic goal. 
 
8.2.2 Evaluation of Dose within the Patient 
Full forward MC calculation of portal dose involves simulating the radiation 
transport throughout the complete patient and EPID geometry, and so in the 
process the MC calculated dose within the patient is also obtained. With simple 
rotation and addition of the DOSXYZnrc generated 3D dose files, the MC calculated 
dose within the patient can also be compared directly with the calculated TPS 
dose, providing an additional check of the TPS dose calculation for the patient 
plan. Of the 8 cases involved in the MC portal dose study (see above), the MC 
calculated dose within the patient was compared with TPS calculated dose for two 
IMRT plans, one head and neck and one prostate. Patients 2 and 5 from table 8.1 
were chosen as representative plans for this purpose. 
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Absolute calibration of the MC dose within the patient was performed using a 
similar method to absolute dose calibration of a linear accelerator. At our centre, 
linear accelerators are calibrated so that 100 MU is equal to 100 cGy at dmax for a 
(10 × 10) cm2 field at 100 cm SSD. All calibration measurements are performed at 
5 cm deep, however, and converted to the dose at dmax, as there are fewer 
uncertainties in measurement due to set-up and electron contamination at depth. 
In a similar way, the MC model of the linear accelerator was calibrated by 
calculating the MC dose at 5 cm depth in water for a (10 × 10) cm2 field and a 
correction factor applied so that 100 MU gave a dose of 100 cGy at dmax. 
 
Conventionally treatment planning system algorithms calculate dose to water, 
whereas MC calculates the energy deposited per unit mass, or dose, to a particular 
medium. Therefore, in order to evaluate agreement between MC and TPS 
calculated dose, the MC dose to medium would first need to be converted to dose 
to water using Bragg Gray Cavity theory by application of stopping power ratios 
for the medium and for water (Siebers et al. 2000). However, all OMP treatment 
plans evaluated here were calculated using the OMP CC ‘enhanced’ algorithm, 
which calculates dose to medium and so no conversion from dose to medium to 
dose to water was required. Comparison against the OMP pencil beam algorithms 
would require this correction and so this would need to be considered in any 
additional investigations comparing the MC calculated dose with pencil beam 
calculated plans. However, due to the known weaknesses of the pencil beam 
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algorithm in heterogeneous patient anatomy its use is likely to be phased out and 
was therefore not used as a comparator in this work. 
 
OMP calculated doses were compared against MC generated doses using the 2D 
gamma evaluation method, slice by slice, for a 20% dose threshold using gamma 
‘pass’ criteria of 3%, 3 mm. An overall gamma pass value for the plan was obtained 
by calculating a weighted mean of the percentage of points passing for all slices 
(the gamma pass value for the slice was weighted dependent on the area of each 
slice with greater than the 20% dose threshold).  
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8.3 Results 
8.3.1 Full Forward Calculation of Portal Dose 
For the 68 exit dosimetry beams evaluated from the 8 patient plans considered, an 
average of 96.6% of points within the 20% dose threshold passed gamma criteria 
of 5%, 5 mm when using the forward MC method. The results are summarised in 
table 8.1. It should be noted that all beams exiting via couch bars were omitted 
from these results. The TPS based technique described in the previous chapter 
gave an average gamma pass of 96.0% when using the same criteria (table 7.1). It 
can be seen that the MC technique gave a slight, but insignificant (very much less 
than one standard deviation), improvement in results. This was somewhat 
surprising as a greater improvement in the verification results was expected using 
the MC technique, MC being widely accepted as the most accurate patient dose 
calculation method.  However, as discussed in the previous chapter, dose 
discrepancies greater than 5% are likely to be due to changes in patient anatomy 
between pre-treatment CT scan and treatment or due to incorrect positioning of 
the patient during treatment. The availability of a treatment-time CT scan would 
obviously enable this to be confirmed. It can be seen that there is a particularly 
low gamma pass rate and high standard deviation for patient 6, this being the 
same patient identified as having a very full bowel for the pre-treatment scan in 
Chapter 7 section 3.5. Figure 8.5 shows the acquired image, MC simulation result, 
gamma map and percentage difference map for beam 6 from patient 6. The 
‘beam’s eye view’ in this case is shown in Figure 7.13. It can be seen that there is 
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generally very good agreement between MC simulation and acquired image, the 
area failing the gamma criteria corresponding to patient bowel, which was full 
during the pre-treatment scan and so not readily reproducible. 
Patient 
Number 
Region Number 
of beams 
Average percentage of 
points passing gamma 
5%, 5 mm 
Standard 
deviation, σ 
1 Head and 
neck 
14 97.5 1.7 
2 8 98.0 1.4 
3 10 97.1 2.5 
4 5 94.9 3.1 
5 Prostate plus 
nodes 
8 99.1 0.7 
6 10 90.5 11.7 
7 7 98.0 2.7 
8 6 97.5 1.7 
Overall 
Average 
  96.6 3.2 
Table 8.1. IMRT verification results for MC exit dosimetry technique. 
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Figure 8.5. Results for beam 6 patient 6. A) Acquired patient EPID image, B) MC 
simulation, C) Gamma map for 5%, 5 mm, D) Percentage difference between acquired 
image and MC simulation. It should be noted that for images C and D the area outside the 
beam is excluded from the calculation and therefore should not be interpreted according 
to the colour scale. 
 
 
 
 
All results to date have omitted beams exiting through treatment couch bars, 
which attenuate the beam by 10% (figure 8.6). If these couch bars were static it 
would be easy to incorporate them within the MC simulation, but unfortunately 
the bars are moveable to enable posterior beams to avoid them, as beam entry 
through a couch bar would significantly affect the patient dose. Correction for the 
effect of the bars is made more difficult by this movement when evaluating 
anterior and anterior-oblique beams exiting through them. However, the new 
Varian couches no longer have these highly attenuating bars, and so updating to a 
new couch system will remove this problem.  
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Figure 8.6. Percentage difference between MC simulation and acquired image for a beam 
exiting a couch bar. It should be noted that the area outside the beam is excluded from the 
calculation and therefore should not be interpreted according to the colour scale. 
 
 
 
 
8.3.2. MC Evaluation of Dose within the Patient 
There was very good agreement between MC simulation and the OMP collapsed 
cone ‘enhanced’ calculation of the IMRT patient dose distribution for both the 
head and neck plan (patient 2) and the prostate plan (patient 5) evaluated. An 
average of 98.3% of points (plan 2) and 95.7% of points (plan 5) passed gamma 
criteria of 3%, 3 mm.  
 
Figure 8.7 shows the OMP calculated dose distribution, the MC calculated dose 
distribution and resulting gamma map for a sample CT slice for the prostate plan 
evaluated. It can be seen that although there is very good agreement between the 
two calculation methods, the OMP calculated dose is 2% to 3% lower towards the 
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centre of the patient. A dose difference of 2% in this region would be expected as 
OMP overestimates the electron density for adipose and fat tissues as discussed in 
the previous chapter. OMP currently assigns an electron density of 0.95 for HU of  
-96, whereas it should be about 0.92. For prostate patients with large amounts of 
adipose tissue this small difference would therefore be expected at the centre of 
the patient.  
 
Figure 8.7. A) The MC calculated dose distribution (in Gray) for one CT slice for the 
prostate IMRT plan , B) OMP calculated dose distribution for the same CT slice and C) 
gamma map for the slice (for a 20% dose threshold). NB The area outside the patient 
should not be interpreted according to the colour scale. 
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Figure 8.8. A) The MC calculated dose distribution (in Gray) for one CT slice for the head 
and neck IMRT plan , B) OMP calculated dose distribution for the same CT slice and C) 
gamma map for the slice. NB The area outside the patient should not be interpreted 
according to the colour scale. 
 
 
Figure 8.8 shows the OMP calculated dose distribution, the MC calculated dose 
distribution and resulting gamma map for a sample CT slice for the head and neck 
plan evaluated. The overall gamma pass for this plan was 95.7%, and close 
inspection of results for all slices revealed that the plan consistently failed the 
gamma criteria in regions where HU is in the range 75 to 175. From figure 8.4 it 
can be seen that this range of HU falls in the area that corresponds to a change in 
gradient of the electron density to HU curve, and we currently have no data for 
CHAPTER 8. MONTE CARLO PATIENT DOSE VERIFICATION                                                          
 
159 
 
this particular region. Removing the voxels with HU in the range 75 to 175 from 
the evaluation improved the overall gamma pass from 95.7% to 98.1%. Data in 
this range is therefore of limited accuracy and further investigation needs to be 
carried out to establish the correct electron density to HU conversion to use for 
our scanner in this range.   
 
 
 
8.4 Conclusions 
A full forward MC exit dosimetry technique has been developed. Evaluation of 
patient exit EPID images acquired during treatment produced very good results 
with an average of 97% of points passing gamma criteria of 5%, 5 mm. Areas 
failing these criteria were found to correspond to changes in anatomy between 
pre-treatment planning CT scan and treatment. This technique obtained 
marginally better results on average than the INTREPID technique described in the 
previous chapter, and would be suitable for the verification of the delivery of 
patient IMRT plans during treatment as a stand-alone method, or as a back-up 
system to aid in investigations when alternative methods fail the accepted gamma 
criteria. 
 
The advantage of the full forward MC exit dosimetry technique is that in the 
process the MC dose within the patient is calculated ‘for free’ with no additional 
resources required. This MC calculated dose within the patient can be used to 
confirm the TPS calculated dose distribution before treatment. This is particularly 
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useful for complex IMRT plans that stretch the ability of MU check calculation 
programmes, and where confirmation of dose at a single point is meaningless. For 
this reason many centres still verify all their IMRT patient plans on a phantom 
before treatment, however many of these phantoms are homogeneous and so this 
does not confirm the TPS dose calculation within the heterogeneous patient media. 
The MC exit dosimetry technique described as a part of this chapter would enable 
full 3D verification of the TPS calculated dose distribution whilst additionally 
verifying the delivery of the plan at treatment-time. 
 
The results in this chapter were presented in part at the Second European 
Workshop on Monte Carlo Treatment Planning (Cufflin et al. 2009b). 
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Chapter 9 
Conclusions 
 
9.1 Summary 
This work has focused on the development of EPID dosimetry techniques 
applicable to the verification of IMRT, the following aspects in particular. 
1. A MC modelling solution devised to correct for non-uniform backscatter 
to the imager from supporting structures has been developed (Chapter 
4, Cufflin et al. 2010a). The solution involved adding different 
thicknesses of water equivalent material to the back of the MC EPID 
model until MC simulated ‘flood’ images best matched the raw flood 
images. Although relatively simple, this method has proved efficient at 
correcting for the effects of non-uniform differential backscatter for all 
field sizes both on and off-axis. This solution has enabled the MC 
verification of large, clinical IMRT fields covering almost the entire 
detector area (Chapter 5). Incorporating this correction for non-
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uniform backscatter greatly improved gamma pass-rates for the IMRT 
fields evaluated, the number of points passing gamma criteria of 2%, 2 
mm improving from 78.6% to 95.7% for the complex head and neck 
case investigated. 
2. The work in Chapter 5 proved MC portal dosimetry to be a particularly 
sensitive dose verification tool, accurate enough to detect real sub-MU 
delivery errors (Cufflin et al. 2008). 
3. This work has developed a method for predicting acquired EPID images 
by calculating the dose in water at the EPID level within the TPS and 
applying a series of correction factors, based on MC simulation and 
measurement, to convert to EPID image intensity. INtegrated 
TReatment Planning and EPID Dosimetry (INTREPID) has been applied 
both pre-treatment (Chapter 6, Cufflin et al. 2009a) and to verify 
delivery during treatment (Chapter 7, Cufflin et al. 2010b, 2010c) 
achieving very satisfactory verification results. When applied pre-
treatment, INTREPID is a very time efficient process, requiring 10 
minutes per patient on the linac and taking only a few minutes to 
calculate on the TPS. When applied for verification during treatment, 
INTREPID calculation times are similarly time efficient. To date a total 
of 68 beams from 4 head and neck and 4 pelvic plans have been 
evaluated, with an average of 96% of points passing gamma criteria of 
5%, 5 mm. Additionally, the technique has also proven its ability to pick 
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up dose delivery errors due to changes in patient position or patient 
anatomy. 
4. A novel, field-size and position dependent matrix-based correction for 
the non-uniform backscattering materials to the rear of the imager has 
been developed (Chapter 6). This solution can be applied to all EPID 
dosimetry techniques, regardless of calculation method. When 
incorporated into INTREPID the devised correction for non-uniform 
backscatter improved agreement between predicted and measured 
EPID intensities. Average pre-treatment gamma pass results for 3%, 3 
mm are improved from 96% (σ = 3.3) to 98% (σ = 1.6), with a 
significant improvement of results for any fields with small segments 
off-axis in the target direction.   
5. A full-forward MC exit portal dosimetry technique has been developed 
for the a-Si EPID (Chapter 8), incorporating the modelling of the 
backscattering components as described in Chapter 4. Use of the RTGrid 
service and optimisation of MC simulation parameters enables results 
of clinical IMRT plans to be obtained overnight. Evaluation of patient 
exit EPID images acquired during treatment produced very good results 
with an average of 97% of points passing gamma criteria of 5%, 5 mm. 
Areas failing these criteria were found to correspond to changes in 
anatomy between pre-treatment planning CT scan and treatment. The 
advantage of the full forward MC exit dosimetry technique is that in the 
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process the MC dose within the patient is also calculated with no 
additional resources required. This MC calculated dose within the 
patient can be used to confirm the TPS calculated dose distribution 
before treatment. 
 
9.2 Further Work and Discussion 
One of the weaknesses of this work is the current unavailability of treatment-time 
CT images on our Varian linacs to confirm any changes in patient position or 
anatomy between planning CT and treatment. When this data becomes available 
the techniques described in this work can be adapted to calculate the treatment 
time dose projection.  The MC technique will additionally provide information on 
how any differences in patient anatomy influence the dose delivered to the 
patient.  
 
INTREPID, the TPS based EPID dose prediction method presented as a part of this 
work, modelled a ‘water equivalent EPID’ within the planning system requiring 
factors to convert from dose in water to dose in EPID and to correct for field size 
output factors in different materials. On the other hand, the BEAMnrc MC methods 
developed have simulated dose to the EPID directly, and so such correction factors 
are not required. It is anticipated, however, that Nucletron will introduce a MC 
photon dose calculation option within OMP in the near future. When the MC 
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option is available it may enable accurate calculation of dose to high density 
materials such as those in the EPID. This would therefore allow for the accurate 
modelling of EPID plus backscattering supporting materials within OMP, removing 
the need for correction factors and simplifying the INTREPID method. 
 
Many centres are now moving towards delivering IMAT (Intensity Modulated Arc 
Therapy), a form of IMRT that delivers radiation as single or multiple continuous 
arcs as opposed to delivery at discrete ‘gantry’ angles. IMAT is attractive as it is 
able to provide highly conformal dose distributions comparative to those of IMRT, 
but with increased delivery speed.  A technique offering increased delivery speeds 
is appealing as this enables greater patient throughput and therefore reduction of 
patient waiting times. A number of treatment planning systems calculate IMAT 
plans by splitting the arc into discrete beams every 4° or so around the patient, 
increasing the number of discrete beams increasing the dose calculation accuracy. 
This IMAT dose calculation method could be applied directly to the EPID dose 
prediction techniques described in this thesis, enabling direct adaptation of the 
techniques to IMAT deliveries.  
 
All work in this thesis has compared acquired EPID images with predicted images 
at the EPID level, enabling quick analysis of delivery at the treatment unit and 
simple analysis of the origin of any errors. However, many published approaches 
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back-project the EPID images to enable delivered dose calculation within the 
patient, for comparison against the planned TPS dose distribution (van Elmpt et al. 
2007, van Elmpt et al. 2008b, Wendling et al. 2006). Most centres performing 
routine back-projection of EPID images have Elekta or Siemens linacs, and the 
author is unaware of any back-projection methods that include a correction for 
the Varian non-uniform backscatter issue. Dosimetry Check, a commercial 
solution that claims to be available for all linac manufacturers, does not include 
such a correction. This thesis has shown these backscatter effects to be significant 
for the large IMRT fields, for head and neck or prostate plus nodal treatments, 
delivered at our centre. As already stated, the novel matrix-based correction 
method developed as a part of this work is versatile and could be adapted to be 
included in all EPID dose calculation methods.  
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Appendix 2: Glossary of Abbreviations 
This glossary gives a list of abbreviations used in this thesis. 
 
BCA   Boundary Crossing Algorithm. The algorithm used to transport 
  particles across boundaries in Monte Carlo simulations. 
CC  Collapsed Cone. A dose calculation algorithm used in radiotherapy 
  treatment planning systems (see section 2.2.2). 
CPU  Central Processing Unit. The central processing unit of a  
  computer. 
DBS  Directional Bremsstrahlung Splitting. A variance reduction  
  technique used in BEAMnrc Monte Carlo simulations (see section 
  2.1). 
dmax  Depth of Maximum Dose. Depth of maximum dose on the central 
  axis of a radiotherapy beam.  
DRR  Digitally Reconstructed Radiograph. A radiograph reconstructed 
  from CT data.  
DTA  Distance to Agreement. 
ED  Electron Density. The number of electrons per unit volume. In 
  radiotherapy the ED of a material relative to that of water is  
  usually quoted. 
ECUT  Electron Transport Cut Off. If an electron energy falls below the 
  transport cut off, the particle trajectory is terminated and its energy 
  deposited in the current region. 
EGS  Electron Gamma Shower. The EGS computer code system is a  
  general purpose package for the Monte Carlo simulation of electron 
  and photon transport.  
EPID  Electronic Portal Imaging Device. EPIDs capture radiotherapy 
  beam transmission images and are primarily used to verify the  
  patient position during treatment, but they also have the potential 
  to be used as efficient dose verification tools of high spatial  
  resolution.  
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EWWF Equivalent Window Width Field. A first-order approximation of 
  the equivalent square field size for MLC shaped apertures (see  
  section 6.2).  
FSF  Field Size Output Factor. Ratio of output at dmax for a reference 
  field (usually 10 cm × 10 cm) to output at dmax for a given field size. 
  It should be noted that this definition used in this thesis, and at VCC 
  is the inverse of the factor used at many other centres. 
HTC  High Throughput Computing. The use of many computing  
  resources to accomplish a computational task. 
HU  Hounsfield Units. Hounsfield Units, or CT numbers, represent the 
  difference in X-ray attenuation between a given material and water. 
ICRU  International Commission on Radiation Units. Organisation  
  whose principal objective is the development of internationally 
  acceptable recommendations regarding quantities and units of  
  radiation. 
IGRT  Image Guided Radiotherapy. IGRT utilises images, such as EPID or 
  cone beam CT images, to improve accuracy and precision of  
  treatments. 
IMAT  Intensity Modulated Arc Therapy. Radiotherapy treatment  
  achieving high conformity to the tumour volume by dynamic  
  movement of the linac gantry and MLCs during treatment. 
IMRT   Intensity Modulated Radiotherapy. Radiotherapy treatment  
  achieving high conformity to the tumour volume by modulating the 
  beam profile using moving MLCs during treatment (section 1.3). 
INTREPID  INtegrated TReatment Planning and EPID Dosimetry. Technique 
  developed as a part of this work to calculate the dose at the EPID 
  utilising the treatment planning system and a series of derived  
  correction factors (see chapters 6 and 7). 
IPEM  Institute of Physics and Engineering in Medicine. UK Registered 
  charity that promotes the advancement in physics for medical  
  benefits. 
KERMA Kinetic Energy Released per unit Mass. KERMA is the energy 
  released in a medium, per unit mass, by indirectly ionising radiation.   
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Linac  Linear Accelerator. A type of particle accelerator in which charged 
  particles are accelerated by means of oscillating electric fields. They 
  are used for the production of X-rays and electrons for therapeutic 
  purposes (radiotherapy). 
MC  Monte Carlo. Monte Carlo methods simulate physical processes 
  utilising probability distributions and random number   
  generators (statistical sampling). 
MLC  Multileaf Collimator. Beam shaping device made of many high 
  density narrow ‘leaves’ (see section 1.3). 
MU  Monitor Units. Calibrated radiotherapy machine unit. 
NGS  National Grid Service.  A HTC service that provides computing 
  power for all that require it by simply ‘plugging in’. 
NKI  Netherlands Cancer Institute. Key research and cancer institute 
  based in Amsterdam. 
NTCP  Normal Tissue Complication Probability. Prediction model of the 
  biological effect of radiation to healthy tissues. 
OAR  Organs at Risk. Healthy critical organs in close proximity to the 
  radiotherapy treatment area. 
OMP  Oncentra MasterPlan. Treatment planning system from Nucletron 
  (The Netherlands) for the preparation of radiotherapy treatment 
  plans and calculation of patient dose. 
PB  Pencil Beam. A dose calculation algorithm used in radiotherapy 
  treatment planning systems (see section 2.2.2). 
PCUT  Photon Transport Cut Off. If the photon energy falls below the 
  transport cut off, its trajectory is terminated and the energy  
  deposited in the current region. 
PTV  Planning Target Volume. The tumour plus margins allowing for 
  uncertainties and variations in tumour location and patient  
  positioning. 
QC  Quality Control. A process that is used to ensure a certain level of 
  quality in a product or service, for example, the routine examination 
  and testing of the quality of products.  
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SDD  Source to Detector Distance. Distance between the accelerator 
  source and the measuring detector. 
SLIC  Scanning Liquid Ion Chamber. Older version of an EPID utilising a 
  liquid ionisation chamber.  
TCP   Tumour Control Probability. Prediction model of the biological 
  effect of radiation in controlling tumour growth.  
TERMA Total Energy Released in the Medium. Quantity used in CC  
  calculation algorithms (see section 2.2.2). 
TPS  Treatment Planning System. Computer system used for the  
  preparation of radiotherapy treatment plans and calculation of 
  patient dose.  
 
VCC   Velindre Cancer Centre. VCC in Cardiff, Wales, is one of the largest 
  cancer centres in the UK, providing specialist cancer services to over 
  1.5 million people in South East Wales and beyond. 
 
 
